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Summary 
 
Before a mature spermatozoon is able to fertilise the oocyte, it must first traverse the 
female reproductive tract, through obstacles such as highly viscous mucus. As the 
sperm is thought to be transcriptionally and translationally inactive, it must rely on 
cues from its external environment in order to alter its function. Membrane-localised 
ion channels are fundamental in this process, where activation/inhibition of the 
channel results in modification of intracellular ion concentrations, resulting in change 
in behaviour of the sperm, in particular sperm motility. The sperm-specific calcium-
permeable cation channel CatSper is necessary for initiation of hyperactive motility in 
murine spermatozoa, and was previously identified to be disrupted in sperm from an 
infertile patient. However, little is known about the incidence of CatSper defects in 
the IVF (in-vitro fertilisation) patient population. 
In the present study two groups of patients, 1) IVF patients and 2) IVF or ICSI (intra-
cytoplasmic sperm injection) patients who had experienced a cycle of low/failed 
fertilisation were screened for defects in calcium regulation and particularly CatSper 
function. In a novel finding, one patient from each of these groups were found to have 
normal semen analysis, yet sperm were found to have a complete absence of calcium 
response to progesterone, thus indicating CatSper dysfunction.  
This study also investigated the effect of cryopreservation on human sperm function, 
with particular reference to calcium regulation. Cryopreservation was able to 
significantly diminish the calcium response to progesterone, basal hyperactivation and 
penetration into viscous media. The assay identified a subset of donors who were 
particularly susceptible to cryodamage, which may be of significant clinical relevance, 
due to the common use of cryopreservation of semen in ART. The present study also 
xiv 
 
describes the novel use of single cell calcium imaging as a sensitive screening tool for 
calcium defects in healthy volunteer donors, IVF and ICSI patients, thus enabling 
study of sperm samples of low concentration, particularly relevant for male infertility 
patients exhibiting oligozoospermia.  
xv 
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Chapter 1 
General Introduction 
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1.1 Infertility 
1.1.1 Subfertility, infertility and the use of assisted reproductive technologies 
Clinical infertility is defined by the World Health Organization (WHO) as a disease 
of the reproductive system, characterised by the failure of a couple to conceive after 
12 months of regular unprotected intercourse (Zegers-Hochschild et al., 2009).  The 
WHO (World Health Organization, 1992) estimates that around 10-15% of couples 
trying to conceive will experience infertility or subfertility and will require assisted 
conception: infertility may be as a result of female, male, or a mixture of female and 
male or of unexplained origin  (Department of Health, 2009). Infertility is a significant 
global health issue, with an estimated 72.4 million people affected by infertility 
worldwide (Boivin et al., 2007). The development of assisted reproductive 
technologies (ART) as treatments for infertile patients led to the birth of the world’s 
first ‘test tube baby’ Louise Brown in 1978 via the in vitro fertilisation of a single 
oocyte extracted laparoscopically (Steptoe and Edwards, 1978). This is now a 
mainstream treatment. It was announced in 2012 that over 5 million babies have now 
been born by assisted conception worldwide (Ferraretti et al., 2012) and the number 
of ART cycles is increasing by 3.9% each year (HFEA, 2014).  
ART consists of multiple in-vitro techniques to assist achievement of a pregnancy, 
including intra-uterine insemination (IUI) for mild infertility, in vitro fertilisation 
(IVF) for moderate infertility, or intra-cytoplasmic sperm injection (ICSI) for severe 
infertility, as well as gamete/embryo cryopreservation and frozen embryo transfer 
(Zegers-Hochschild et al., 2009). In the UK, over 60,000 cycles of IVF and ICSI are 
performed annually, at a proportion of 47.4% versus 52.6% respectively (HFEA, 
2014). Although the introduction of assisted reproductive techniques has enabled 
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pregnancies and live births for many otherwise infertile couples, the success rate of 
live birth per cycle remains low at 26.5% for women of all ages (HFEA, 2014). 
Furthermore, the likelihood of pregnancy is reduced following multiple unsuccessful 
IVF cycles, with a particularly sharp decrease in pregnancy rates after the third cycle 
of IVF where the first two cycles have failed to produce a pregnancy or live birth 
(Martin-Johnston et al., 2009). 
1.1.2 Fertilisation failure in ART 
It is estimated that around 5-20% of all IVF cycles will result in total fertilisation 
failure (Johnson et al., 2013), with a fertilisation failure recurrence rate in subsequent 
IVF cycles of 30-67%. Total fertilisation failure in ICSI is lower, estimated to be 
around 1-3%, with low fertilisation in up to 14% of cases, with factors including 
inability of the oocyte to become activated by the sperm (Flaherty et al., 1995, 
Saunders et al., 2002, Esfandiari et al., 2005).  
The occurrence of failed fertilisation is often unpredictable and with no obvious 
identifiable male or female deficiency. However, it has been estimated that low sperm 
binding is the largest cause of failed fertilisation in IVF, where <5 of the partner’s 
sperm are found to be tightly bound to the oocyte. In this study by Liu and Baker, it 
was found that addition of donor sperm to the oocyte resulted in many more sperm 
bound, indicating a primary problem with the partner’s sperm and not with the oocyte 
itself (Liu and Baker, 2000). Failed fertilisation in IVF due to defective sperm-oocyte 
binding and penetration may be overcome in subsequent cycles by the employment of 
the ICSI technique, to bypass the functional requirement of the sperm to penetrate the 
oocyte. It is clear that fertilisation events are currently poorly understood. Further 
research must be carried out in order to characterise this, in order to understand the 
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causes leading to failed fertilisation, to predict its occurrence and ultimately identify 
appropriate treatment options for patients to avoid it. 
1.1.3 Prevalence of male factor fertility 
It is currently estimated that male factor infertility now contributes to up to half of all 
causes of infertility seen in the assisted conception clinic (Massart et al., 2012). 
Defects in sperm function are thought to be the most significant cause of male 
infertility (Hull et al., 1985), however there is currently no drug to stimulate in vivo or 
in vitro increase in sperm fecundity (Barratt et al., 2011). Multiple studies have 
reported a decrease in semen parameters with age or over time (Carlsen et al., 1992, 
Auger et al., 1995, Eskenazi et al., 2003, Rolland et al., 2012, Johnson et al., 2015). 
Currently, the sole assisted reproductive option for severe male factor infertility is 
ICSI, a highly invasive practice with risks of damage to oocytes, with potential 
increased risk of genetic/epigenetic conditions in children conceived (HFEA, 2009). 
Male factor infertility is a serious and widespread condition, currently lacking in 
adequate non-invasive treatment solutions in the ART repertoire.  
 
1.2 Semen Analysis 
To determine if male factor is the source of infertility, a basic semen analysis (SA) is 
performed according to WHO 2010 guidelines to determine the quality and quantity 
of sperm present in the ejaculate (Cooper et al., 2010, World Health World Health 
Organization, 2010). SA is currently the gold standard in assessing the function of the 
male reproductive system. Sperm concentration, total sperm count, volume of semen, 
percentage of motile sperm (progressive PR + non-progressive NP), percentage of 
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progressively motile sperm (PR), percentage of normal forms of sperm (including 
head, neck/midpiece/tail defects and cytoplasmic droplets), MAR (mixed antiglobulin 
reaction) test for antisperm antibodies (Scarselli et al., 1985) and pH tests on 
azoospermic samples are all analysed by the andrologist according to the WHO criteria 
for normal human semen (Cooper et al., 2010). Normal semen characteristics are 
provided in Appendix Table 1. 
Samples exceeding the 5th centile values, and therefore found to be characteristically 
normal, tend to be allocated to IVF treatment. There are currently no medical 
interventions to improve fertility for male patients with a testicular or unknown cause 
of infertility (Khorram et al., 2001), therefore if a sample exhibits oligo- (low sperm 
concentration), astheno- (poor sperm motility) or teratozoospermia (poor sperm 
morphology), or a combination of these characteristics, ICSI treatment will be used to 
bypass the functional requirements of sperm and to improve the likelihood of 
successful fertilisation (Liu and Baker, 2002). ICSI is also used in cases where sperm 
are surgically retrieved from the testis, or if a previous IVF cycle has resulted in failed 
fertilisation of all oocytes incubated with sperm, indicating defective sperm-oocyte 
binding or an inability of the sperm to penetrate the oocyte (Khorram et al., 2001).  
SA provides an indication whether male factor contributes to a couple’s infertility and 
which of the assisted reproductive techniques is best suited to overcome this (Huang 
and Rosenwaks, 2012). However SA values of fertile males and men with male factor 
infertility display significant overlap between the groups: morphology has been 
demonstrated to have poor specificity (0.51), while sperm concentration also gives 
poor sensitivity between these groups (0.48) (Nallella et al., 2006). Furthermore, 
patients with impaired sperm function will not show obvious abnormalities during 
routine SA, therefore these couples could be described as having ‘unexplained 
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infertility’ (Sánchez et al., 2013). SA, although widely used, has limited diagnostic 
value and further research into identification of the potential causes underlying 
unexplained infertility must be performed, in order to more accurately interrogate 
gamete capability, and to tailor ART to treat infertility in these couples (Sánchez et 
al., 2013, Wang and Swerdloff, 2014).  
 
1.3 Sperm function and quality tests 
SA alone shows the quality of sperm motility and raw sperm concentration, and is 
taken as a surrogate assessment of fertility, however is unable to show functional 
abilities of the sperm (Pacey, 2012). The causes of sperm dysfunction are largely 
unknown, therefore several bioassays have been developed in an attempt to accurately 
analyse sperm function, and to diagnose male factor infertility, however these have 
not yet been widely adopted for clinical use (Sánchez et al., 2013, Wang and 
Swerdloff, 2014). These tests include the hypoosmotic swelling (HOS) test for vitality 
(Jeyendran et al., 1984), DNA damage analysis (Aitken et al., 2009, Robinson et al., 
2012, Simon et al., 2013), hemizona binding assay (Oehninger et al., 2013) hyaluronic 
acid binding assay (Worrilow et al., 2013, Mokanszki et al., 2014), and analysis of 
reactive oxygen species (ROS) (Guthrie and Welch, 2012). Although many varied 
sperm function tests are offered as adjuncts to treatment in some clinics, there are very 
few clinical trials to back up the relevance of these tests to success in ART, are 
introduced to the repertoire without stringent testing being performed, and parameters 
have yet to be defined for the normal population (Harper et al., 2012). The tests 
selected for this thesis were thought to most accurately represent in vivo physiological 
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processes sperm encounter prior to fertilisation: penetration through viscous media, 
calcium response to progesterone, and initiation of hyperactivated motility. 
1.3.1 Viscous media penetration test 
In vivo, during sperm transit through the female reproductive tract, the motile cells 
encounter two areas containing highly viscous solutions: 1) the cervical mucus and 2) 
the cumulus-oocyte complex composed of hyaluronan. The Kremer penetration test 
was devised to assess the sperm’s ability to penetrate these viscous fluids. Only 
competent, morphologically normal spermatozoa were found to be able to penetrate 
cervical mucus (Jeulin et al., 1985). The test (Kremer, 1965) originally used human 
cervical mucus obtained from healthy donors. However due to the ethical issues and 
impracticalities surrounding obtaining human cervical mucus, including cyclic 
variability in constitution and viscosity, and the lack of a suitable animal alternative, 
a synthetic cervical mucus substitute, methylcellulose, is now used (Ivic et al., 2002, 
Alasmari et al., 2013b). Its viscosity is 4000cP (centipoise) which closely resembles 
that of mid-cycle cervical mucus (Ishijima et al., 1986). The ability of the sperm to 
progress through cervical mucus is thought to be positively correlated with the fertility 
of these sperm (Berberoglugil et al., 1993), as well as their ability to penetrate cumulus 
cells held in a viscous jelly-like hyaluronan matrix in vivo in order to reach the oocyte.  
1.3.2 Basal and stimulated hyperactivation 
Significant levels of hyperactivated motility are available only after exposure to 
capacitating conditions (see section 1.5 and 1.6). This transition from activated to 
hyperactivated motility is  postulated to enable sperm detachment from the oviductal 
epithelium, and to aid progression through visco-elastic obstacles encountered during 
sperm transit through the female reproductive tract, including cervical mucus and 
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cumulus cell matrix, as further described in section 1.6 (Suarez et al., 1991). Indeed, 
murine sperm that cannot hyperactivate, are unable to penetrate and therefore fertilise 
oocytes (Quill et al., 2003). Infertility patients have previously been found to exhibit 
reduced proportions of hyperactivated spermatozoa, which may contribute to their 
infertile status (Munire et al., 2004, Alasmari et al., 2013a). 
Hyperactivation is dependent on increases in [Ca2+]i (Suarez and Ho, 2003) either by 
activation of intracellular calcium stores or by activation of bivalent cation channels 
such as CatSper (Bedu-Addo et al., 2008, Suarez, 2008). Hyperactivated motility has 
previously been shown to be induced artificially by addition of calcium store 
mobilizing agents such as 4-aminopyridine (4-AP) (Gu et al., 2004, Alasmari et al., 
2013a), which may be of significant clinical benefit for patients where the proportion 
of hyperactivated spermatozoa is significantly reduced. 
1.3.3 Calcium response to progesterone 
Many studies have correlated male factor infertility with sperm calcium response to 
progesterone: in oligozoospermic patients (Falsetti et al., 1993), patients with 
reduced/failed fertilisation (Krausz et al., 1995), and teratozoospermic patients 
(Oehninger et al., 1994). More recently, the calcium response to progesterone has been 
attributed to non-genomic CatSper channel activation by the steroid hormone, as 
described in section 1.7 (Strunker et al., 2011, Brenker et al., 2012). Absence of the 
functional CatSper channel complex in mice translated into inability to hyperactivate 
or penetrate the oocyte ZP (Quill et al., 2003), however contrary to the human model, 
CatSper does not appear to be activated by progesterone. In 2013, electrophysiological 
analysis of the sperm of a CatSper-deficient infertile patient revealed absence of the 
CatSper current under Cs+ based conditions, however there were multiple other 
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abnormalities present (Smith et al., 2013). The CatSper channel therefore has 
significant importance in human male fertility, which certainly warrants further study 
(section 1.7 and section 1.9). 
This thesis aims to utilise the techniques described above to investigate calcium 
pathway defects in patients attending for infertility treatment, to further interpret the 
role of calcium on male infertility. 
 
1.4 Importance of ion channels in sperm function 
Despite the presence of some mRNAs found within sperm cytoplasm (Jodar et al., 
2013), mature ejaculated spermatozoa are thought to be both transcriptionally and 
translationally inactive. Sperm DNA is remodelled by exchanging histones for 
protamines via transition proteins during sperm development and differentiation, and 
is therefore rendered inaccessible to transcriptional cellular machinery (Johnson et al., 
2011). Sperm also shed an abundance of cytoplasm through the maturation process, 
resulting in loss of intracellular organelles and subsequent characteristic streamlined 
sperm morphology. As a result, sperm rely on detection of cues from the surrounding 
environment of the female reproductive tract in order to alter their function, via the 
activation of ion channels present on the sperm phospholipid membrane. Capacitation, 
the acrosome reaction, initiation of hyperactivation, regulation of membrane potential 
and calcium response to progesterone all depend on appropriate ion channel function 
(Shukla et al., 2012). Defective ion channel function therefore inevitably results in 
male infertility, as seen in mice and men (Quill et al., 2003, Smith et al., 2013). The 
following sections will discuss the importance of suitable ion channel function on 
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regulation of sperm function, with particular emphasis on the regulation of 
intracellular calcium. 
 
1.5 Capacitation 
1.5.1 Introduction to capacitation 
Immediately after ejaculation, spermatozoa are unable to fertilise an oocyte. The 
sperm cell must undergo several fundamental biochemical changes, both in natural 
conception and during IVF, before fertilisation is possible. Chang et al (1951) and 
(Austin, 1952) first discovered that in vitro-fertilisation would not occur unless the 
sperm had first been exposed to the female reproductive tract. The resultant 
biochemical and physiological changes in spermatozoa are collectively named 
‘capacitation’, as the sperm has acquired the capacity for fertilisation (Austin, 1952). 
Edwards et al reported in 1969 that during IVF of human oocytes, human sperm 
required around 7 hours to capacitate before being able to penetrate the oocytes 
(Edwards et al., 1969).  
1.5.2 Biochemistry of capacitation 
The intracellular biochemical modifications associated with capacitation include an 
increased fluidity of the sperm plasma membrane, phosphorylation of protein 
serine/threonine and tyrosine residues, an increase in intracellular Ca2+, cAMP and 
HCO3
-, ability to undergo the acrosome reaction, a hyperactivated motility pattern and 
(somewhat controversially) ability to utilise chemotaxis to find the egg (Visconti et 
al., 1995a, Visconti et al., 1995b, Osheroff et al., 1999, Visconti et al., 1999, Fraser, 
2010). Holding the sperm plasma membrane at a negative value (hyperpolarisation) is 
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also linked with capacitation, via postulated combined activation of the SLO1 and 
SLO3 K+ channels (Lopez-Gonzalez et al., 2014, Mansell et al., 2014).  
After ejaculation, sperm exhibit progressive and directional motility with symmetric, 
low-amplitude beats of the flagellum that changes to non-progressive hyperactivated 
motility (see section 1.6), and the ability to undergo the acrosome reaction (AR) 
following capacitation (Baldi et al., 1996, Baldi et al., 2000). When the spermatozoa 
undergoes AR, it reveals an inner plasma membrane, covered with enzymes to aid 
passage through the thousands of somatic cumulus cells (CC) surrounding the oocyte. 
The CC are held in a jelly-like matrix of hyaluronic acid; therefore one of the enzymes 
Figure 1.1 Early and late events in capacitation. Diagram showing the 
bicarbonate /PKA/ tyrosine phosphorylation pathway. Activation of the pathway 
leads to induction of hyperactivation and acrosome reaction: two fundamental parts 
of sperm fertilizing ability. Capacitation is separated into early and late events 
(Battistone et al., 2013). 
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exposed by the AR is hyaluronidase, Hyal5 and Ph-20 (Kim et al., 2008). Sperm must 
hyperactivate before they are able to penetrate through the CC, and reach the oocyte 
zona pellucida.  
The influx of Ca2+ and HCO3
- during capacitation, due to enhanced permeability of 
the more fluid plasma membrane, activates the soluble adenylyl cyclase (sAC) 
enzyme, which then produces cyclic AMP (cAMP) (Figure 1.1). cAMP is then able to 
activate PKA (protein kinase A) (Breitbart, 2002). Protein tyrosine phosphorylation is 
mediated by PKA activity, and Visconti et al (1995) showed that both protein tyrosine 
phosphorylation and capacitation are inhibited when PKA activity is inhibited. PKA 
is spatially organised within the sperm cell by A kinase-anchoring proteins (AKAPs), 
therefore is only present within specific subcellular compartments (Visconti et al., 
1995b, Baldi et al., 2000). The extent of protein tyrosine phosphorylation increases 
with the sperm’s duration of capacitation.  
The proportion of acrosome reacted and hyperactivated sperm in a sample reflects the 
IVF success rate (Sukcharoen et al., 1995, Alasmari et al., 2013a), therefore the 
capacitating media must contain essential components such as Ca2+, HCO3
- and serum 
albumin, which aim to promote capacitation. This increase in HCO3
-, from around 
4mM in the epididymis to over 20mM in the capacitating media, mimics the HCO3
--
rich environment of the female reproductive tract (Gadella and Van Gestel, 2004). 
Moseley et al showed that using IVF media does indeed accelerate capacitation, with 
all the rates of tyrosine phosphorylation, hyperactivation and AR being faster than 
non-capacitating media (Moseley et al., 2005). The media used by the clinic for 
capacitating sperm before the IVF procedure, Quinn’s Advantage® Fertilisation 
(HTF) Medium, has also been shown to enhance the zona pellucida-induced acrosome 
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reaction for human sperm when compared with human tubal fluid (HTF) medium (Liu 
et al., 2011). 
The female reproductive tract regulates the process of capacitation by controlling 
production and location of factors implicated in capacitation, as well as storing sperm 
in the isthmus until needed in mammals, birds and reptiles (Holt and Fazeli, 2016). 
Furthermore the female reproductive tract has been reported to produce a 
chemoattractant gradient for the sperm to follow; in humans, this is thought to be 
progesterone released by the CC (Jaiswal et al., 1999, Teves et al., 2006).  
1.5.3 Clinical relevance of capacitation 
Failure to capacitate may be linked with incidence of male factor infertility (Munire 
et al., 2004, Buffone et al., 2009). Males whose sperm underwent the acrosome 
reaction prematurely were less likely to achieve a successful fertilisation with IVF, 
and more subfertile men had lost their acrosomes spontaneously compared to males 
with normal fertility (Pampiglione et al., 1993). Alasmari et al (2013a) also showed 
that the rate of hyperactivated activity in human sperm, an indicator of capacitation, 
correlated with fertilisation rate in IVF . Conversely, each stage of capacitation could 
be manipulated as a potential target for novel contraceptives. Contraceptives that 
could impair the normal process of sperm capacitation would impact sperm function 
so severely as to render the sperm infertile. 
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1.6 Hyperactivation 
1.6.1 Role of hyperactivation 
Hyperactivated motility has three main roles: to allow sperm to detach from the 
oviductal epithelium, migrate through the viscoelastic oviductal mucus in vivo and 
penetrate the layers of CC surrounding the oocyte in vitro and in vivo (Ho and Suarez, 
2001, Suarez and Ho, 2003, Shukla et al., 2012). Around the time of ovulation, the 
sperm acquire hyperactive motility and changes in the sperm head plasma membrane, 
thus enabling their detachment from the epithelium in the storage region of the female 
reproductive tract (Simons et al., 2014). Hyperactivated sperm motility was first 
described in the golden hamster in 1970 (Yanagimachi, 1970). 
Hyperactive motility has a significant role in zona pellucida penetration in a hamster 
model (Stauss et al., 1995). Furthermore sperm from mice lacking CatSper2 are 
infertile due to their inability to hyperactivate and therefore penetrate the oocyte outer 
vestments (Quill et al., 2003). The importance of hyperactivated motility in human 
sperm has also been highlighted by its reduction in the sperm samples of infertile 
patients (Munire et al., 2004), and demonstration that a population of sperm displaying 
hyperactivated motility had a greater proportion of morphologically normal cells 
(Green and Fishel, 1999). 
1.6.2 Identification of hyperactivated motility  
Hyperactivated motility of the sperm is associated with a vigorous whiplash-like 
movement of the tail with high amplitude asymmetrical beating and non-progressive 
motility. The definition of hyperactivated sperm are those that have a curvilinear 
velocity (VCL)>150, linearity (LIN)<50 and amplitude of lateral head displacement 
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(ALH)>7 (Mortimer et al., 1998). HCO3
- has been shown by Wennemuth et al to 
increase the flagellar beat frequency and therefore motility of murine sperm 
(Wennemuth et al., 2003). Progesterone gradients that mimic those found in vivo on 
the approach to the oocyte are also able to regulate the flagellar beat, via the rise in 
intracellular Ca2+ (Harper et al., 2004, Harper and Publicover, 2005), however do not 
initiate the AR.  
1.6.3 Stimulation of hyperactivated motility with 4-AP 
Gu et al (2004) showed that 4-AP strongly activated hyperactivated motility in sperm 
in vitro, principally by increasing intracellular Ca2+ concentration by mobilisation of 
[Ca2+]i
 stores (Gu et al., 2004, Bedu-Addo et al., 2008). 4-AP was first found to do this 
in neural cells such as neurons and astrocytes, as well as skeletal muscle cells, before 
it was applied to sperm (Grimaldi et al., 2001). This result could be utilised in IVF 
procedures to increase the hyperactivated motility of sperm while it is in close 
proximity to the oocyte, and therefore increase the likelihood of sperm penetration and 
sperm-egg fusion. The amplitude of HA response to 4-AP in IVF patients was also 
correlated with fertilisation rate, and furthermore the proportion of IVF patients with 
HA not significantly stimulated by 4-AP was greater than in healthy volunteer donors 
(Alasmari et al., 2013a). 
1.6.4 Hyperactivation and viscous media penetration 
Strong hyperactivated movements of the flagellum functionally aid the sperm’s 
journey through viscous media such as the oviductal or fallopian tube mucus, and 
disperse the CC that surround the oocyte for access to the ZP (Suarez et al., 1991). 
The Kremer penetration test (as mentioned in section 1.3), is a suitable assay for 
analysing sperm ability to penetrate mucus, as it involves sperm penetration of the 
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resembling viscous media methylcellulose. Sperm that are shown to penetrate 
methylcellulose in vitro are more likely to successfully bypass the cervical mucus, 
which is the first stage of sperm selection in vivo. Hyperactivated sperm have been 
found to be more able to penetrate mucus, as their whiplash movements of the tail in 
more fluid media become powerful progressive strokes in viscous media (Suarez et 
al., 1991), and furthermore both sperm concentration and progressive motility have 
been found to correlate with viscous media penetration (Mortimer et al., 1986). 
1.6.5 Clinical relevance of hyperactivation 
Hyperactivation of human spermatozoa is key for successful fertilisation of the oocyte, 
however is not routinely analysed in the clinical setting as a biomarker for capacitation 
and sperm function. Studies have shown that treatment of sperm with CatSper and 
calcium store-mobilising agents such as NH4Cl, 4-AP and progesterone, along with 
phosphodiesterase inhibitor IBMX, are able to stimulate hyperactivation to varying 
degrees (Alasmari et al., 2013a). This study also revealed that failure to respond by 
increasing hyperactivation levels was more common in IVF patients than research 
donors, (10% versus 2%). Thus, further investigation should be made into the nature 
of these defects, particularly with reference to success at IVF. 
 
1.7 CatSper 
1.7.1 Introduction to the cation channel of sperm (CatSper) 
CatSper channels are promiscuous, sperm-specific cation-permeable ion channels, 
located on the principal piece of the mature sperm flagellum, strongly potentiated by 
alkaline pH and activated by progesterone, ZP proteins, prostaglandins as well as the 
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environmental endocrine disruptor p,p’-DDE (Lishko et al., 2011, Strunker et al., 
2011, Barratt and Publicover, 2012, Tavares et al., 2013). CatSper channels are 
permeable to Ca2+, and the Ca2+ influx that occurs due to CatSper activation is 
necessary for hyperactivation of the sperm in mice (Quill et al., 2003). The CatSper 
channel contains four pore-forming domains coded by the genes CatSper 1 CatSper 
2, CatSper 3 and CatSper 4 (Quill et al., 2001, Ren et al., 2001, Lobley et al., 2003). 
Three auxiliary subunits named CatSper β, CatSper γ and CatSper δ are also present 
(Liu et al., 2007, Wang et al., 2009, Chung et al., 2011).  
In mice, all four knockouts of CatSper genes 1-4 produce the same phenotype: 
infertility due to an inability of the sperm to hyperactivate, and therefore inability to 
generate the necessary force for ZP penetration (Qi et al., 2007). The three auxiliary 
subunits are also necessary for channel function, as knocking out these genes also 
leads to a complete lack of sperm fecundity. The six transmembrane segments of 
CatSper have two distinct roles: segments 1-4 are involved in sensing voltage, 
resulting in the opening and closing of the pore, whereas segments 5 and 6 form the 
actual pore of the channel (Navarro et al., 2008). CatSper proteins 1-4 make up the 
pore-forming domain of the ion channel, and CatSper β, CatSper γ and CatSper δ are 
three auxiliary subunits associated with correct trafficking and assembly of the 
channel proteins (Liu et al., 2007, Wang et al., 2009, Chung et al., 2011). More 
recently, CatSper regulation by progesterone action has been found to be governed by 
the orphan enzyme ABHD2, which removes CatSper-inhibiting endocannabinoid 2-
AG from the sperm membrane (Miller et al., 2016).  
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1.7.2 CatSper dysfunction in mammals 
Although knock-out mice with CatSper 1-4 or δ null sperm appear to be 
morphologically normal, they are infertile. Their inability to sustain the CatSper 
current, Icatsper, is abolished therefore there is no increase in [Ca
2+]i which regulates 
motility and is able to initiate hyperactivation, and therefore the ability to penetrate 
the ZP is abolished (Ren et al., 2001, Carlson et al., 2003, Quill et al., 2003, Qi et al., 
2007), however sperm underwent the acrosome reaction as normal (Navarro et al., 
2008). CatSper KO sperm display slower movements, and are less able to penetrate 
viscous medium, and indeed no eggs were fertilised when co-incubated with CatSper 
null sperm (Quill et al., 2003). However following removal of ZP from the oocyte by 
enzymatic action, the CatSper null sperm were still able to fertilise and activate the 
oocyte (Ren et al., 2001, Navarro et al., 2008).  
In humans, expression of CatSper1 protein has been correlated with progressive and 
hyperactivated motility (Tamburrino et al., 2015), and possibly the progesterone-
induced acrosome reaction (Tamburrino et al., 2014), with mutations in the gene 
causing human male infertility (Avenarius et al., 2009).  
1.7.3 CatSper is a polymodal chemosensor 
CatSper is known as a ‘polymodal chemosensor’ due to its ability to be regulated by 
many different molecules (Brenker et al., 2012). Among these proteins and subunits 
are multiple binding sites for molecules such as progesterone, prostaglandins, menthol 
and odorants such as bourgeonal (Lishko et al., 2011, Strunker et al., 2011, Brenker et 
al., 2012). These molecules are able to activate this cation channel, resulting in 
induction of hyperactivation, motility and chemotaxis. CatSper has been found to be 
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the ion channel responsible for controlling chemotaxis in sea urchin spermatozoa, via 
changing [Ca2+]i (Seifert et al., 2015). 
The steroid hormone progesterone is released by the somatic CC that surround the 
oocyte in the millimolar concentration, and is known to activate the CatSper channel 
and enable Ca2+ influx which aids the change in flagellar beat pattern from activated 
to hyperactivated motility (Lishko et al., 2011, Strunker et al., 2011). Progesterone 
may therefore also serve to trap sperm in the vicinity of the oocyte by inducing non-
progressive hyperactivated movements, where the concentration is the highest, or 
chemotactically draw the sperm to the cumulus-oocyte complex up a progesterone 
concentration gradient, however the employment of chemotaxis by sperm is disputed 
(Jaiswal et al., 1999, Teves et al., 2006, Teves et al., 2009). Both of these proposed 
mechanisms enable the oocyte and the sperm to be in close proximity, thereby 
increasing the likelihood of a sperm penetrating the egg.  
Cyclic nucleotides such as cAMP may indirectly activate CatSper channels by 
activating Na+/H+ exchangers, which modify the intracellular pH to make it more 
alkaline by the extrusion of hydrogen ions (Darszon et al., 2011). This consequently 
activates the pH-sensitive CatSper channels, and introduction of Ca2+ into the sperm 
via CatSper and then proposed Ca2+-induced Ca2+ release from intracellular Ca2+ 
stores, such as the redundant nuclear envelope (RNE) and the acrosome (Olson et al., 
2010). This then activates the sAC/cAMP/PKA pathway, which generates ATP. ATP 
is created by glycolysis, and is used as an energy substrate by dynein motor proteins 
on the axoneme within the flagellum, to allow extended periods of motility and 
hyperactivity. The axoneme is formed of microtubules which slide over each other, to 
produce flagellar bending and therefore sperm motility (Darszon et al., 2011).  
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Influx of Ca2+ at different concentrations regulates distinct sperm functions, for 
example both basal and hyperactivated motility. An increase in the level of 
extracellular Ca2+ is correlated with increased asymmetric flagellar bending, and 
therefore the hyperactivation dependent on CatSper channels in the sperm. 4-
aminopyridine (4-AP) is also known to enhance hyperactivation, which may be due to 
the potentiation of the CatSper current. Costello (2010) showed that use of 4-AP 
caused the release of intracellular stores of Ca2+ at the neck/midpiece of the sperm, 
presumably at the RNE, which stimulated the deep flagellar bends associated with 
hyperactivated motility.  4-AP was also shown to activate CatSper in mice, leading to 
a rise in [Ca2+]i at the principal piece of the flagellum, and also a rise in [pH]i  which 
is known to activate the pH-dependent channel (Chang and Suarez, 2011).  
1.7.4 Effect of intracellular pH  
Control of intracellular pH is particularly important in sperm motility. A high 
incidence of histidine residues within the CatSper ion channel may help to regulate 
intracellular pH (Ren et al., 2001, Navarro et al., 2008). An alkaline pH aids the 
activity of the CatSper channel to increase intraflagellar Ca2+ and induce 
hyperactivation (Kirichok et al., 2006). Alkaline pH is controlled in the sperm cell by 
Hv1 channels, which extrude protons from the cell to raise the [pH]i. These channels 
are closely located to the CatSper channels, on the principal piece of the sperm 
flagellum, and the intracellular alkalinisation caused by Hv1 activates the pH-
dependent CatSper channel (Lishko and Kirichok, 2010). Trimethylamine 
hydrochloride (TMA) is a compound that readily forms a tetramethylammonium ion 
and hydroxide ions in solution (Wu et al., 2012). Its basic property evokes an increased 
[pH]i, which could therefore activate CatSper.  
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1.7.5 Potential contraceptive action 
Drug discovery of ion channel blockers that specifically target the CatSper channel 
could be a potential target for a novel contraceptive, due to its critical role in male 
fertility (Carlson et al., 2009). As CatSper is specifically located in the testis and male 
germ cells, drug therapy may be targeted for localised effects, reducing the incidence 
of adverse side effects. Furthermore, channel antagonists could potentially be utilised 
by either men or women for a contraceptive purpose (Ren et al., 2001). Conversely, 
channel agonists or activators, such as progesterone, could be used to enhance the 
CatSper-dependent hyperactivation observed during capacitation, for beneficial 
results in either natural conception or in assisted reproductive technologies.  
In summary, the CatSper channel is essential for successful fertilisation, due to the 
initiation of hyperactivated motility as seen in a murine model, and is certainly of 
interest in males with unexplained infertility or who have completely failed to fertilise 
oocytes after IVF. Differences in the levels of CatSper expression are relevant for 
patients where motility is compromised (Nikpoor et al., 2004). Furthermore, several 
studies have identified patients with specific CatSper defects: males with 
nonsyndromic male infertility (NSMI) tend to have a mutation in CatSper1, whereas 
males with an infertility and deafness phenotype (DIS- deafness-infertility syndrome) 
have been shown to have a defect in the CatSper2 gene (Hildebrand et al., 2010). 
Intracytoplasmic sperm injection (ICSI) can be used to create an embryo in males with 
defects in CatSper, as ICSI bypasses the requirement for ZP penetration. 
Theoretically, if in the course of infertility investigation a patient’s sperm is identified 
to carry defects in CatSper, IVF may be surpassed in favour of ICSI, due to the 
likelihood of failed fertilisation in IVF. However investigation into the role of CatSper 
on human male infertility relies on the identification of natural CatSper knockout 
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males, which are thought to be rare. Furthermore the incidence of CatSper defects 
within the infertile population is not currently well understood, and therefore clearly 
requires further investigation. 
 
1.8 The role of calcium in sperm function  
[Ca2+]i levels increase in sperm during capacitation (Baldi et al., 2000). There are two 
main mechanisms for the intracellular increase in Ca2+: activation of CatSper, and 
activation of intracellular Ca2+ stores located in the acrosome and at the RNE (Bedu-
Addo et al., 2007, Xia et al., 2007). The spatial organisation of these stores is thought 
to be critical to activate different functions due to Ca2+: the acrosome reaction and 
initiation of hyperactivated motility. 
The balance between [Ca2+]e, present in the female reproductive tract or in media in 
vitro, and [Ca2+]i, is fundamental for normal sperm function (Darszon et al., 2011). 
Maintenance of a low [Ca2+]i concentration is critical for sperm function, which relies 
on the entry of extracellular Ca2+ to modify sperm function (Bhoumik et al., 2014). 
Furthermore increases in calcium above physiological levels has been shown to inhibit 
sperm motility (Williams and Ford, 2001). Regulation of Ca2+ is thought to involve 
several Ca2+ channels, including cation channels of sperm (CatSper, see Section 1.6), 
voltage-operated Ca2+ channels (VOCCs), cyclic-nucleotide gated channels (CNG), 
and store-operated channels (Shukla et al., 2012). The two main stores of Ca2+ are able 
to mobilise and undergo Ca2+-induced Ca2+ release (Bedu-Addo et al., 2008, Costello 
et al., 2009). The spatial differences between the two stores may indicate different 
functional roles and are thought to mobilise in response to different stimuli, therefore 
the acrosomal Ca2+ store may facilitate the acrosome reaction whereas the RNE store 
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is in close proximity to the midpiece and the flagellum and is likely to have a role in 
regulating flagellar movement and hyperactivation (Bedu-Addo et al., 2007). 
Regulation of Ca2+ involves Na+-Ca2+ exchangers and Ca2+ pumps such as Ca2+-
ATPases which serve to buffer the Ca2+ within the cell, and are located on the plasma 
membrane (Jimenez-Gonzalez et al., 2006). Mitochondria, located in the midpiece of 
the sperm, also play a role in sequestering Ca2+. These Ca2+ stores maintain the 
intracellular Ca2+ at a low level, so that when Ca2+ entry into the cell occurs this evokes 
a rapid rise in intracellular Ca2+, which can then bring about many functional changes 
in sperm behaviour. An increase in Ca2+ concentration can either enhance or reduce 
sperm motility (Bhoumik et al., 2014), and its presence is necessary in media in vitro 
or in the human reproductive tract in vivo. Ca2+ binds to calmodulin which enables the 
dynein arms surrounding the microtubules within the sperm flagella to become 
activated, which results in flagellar movement, as described in mice (Schlingmann et 
al., 2007).  
 
1.9 The role of calcium regulation in human male infertility 
The increase in [Ca2+]i in human sperm is integral for successful sperm function due 
to its ability to modify the sperm’s motility, from an activated to a hyperactivated 
status, and stimulation of the acrosome reaction (See sections 1.5, 1.7). It is therefore 
widely believed that the Ca2+ response of human sperm is positively correlated with 
their fertility status. The steroid hormone progesterone is a putative activator of the 
cation channel of sperm (CatSper) (Lishko et al., 2011, Strünker et al., 2011). Defects 
in normal sperm Ca2+ response may result in loss of function of the sperm (Smith et 
al., 2013), and therefore will result in infertility due to inability of the sperm to 
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penetrate the egg. A proposed mechanism for the relationship between CatSper, 
calcium stores and sperm functions such as hyperactivated motility is presented in 
Figure 1.2. 
 
 
 
 
Many studies have looked at the relationship between progesterone-stimulated Ca2+ 
influx, comparing healthy normozoospermic males and infertility patients. The 
question remains: is human sperm Ca2+ response to progesterone a useful biomarker 
Figure 1.2 Calcium regulation in human spermatozoa. This diagram depicts the 
role of [Ca2+]I from CatSper activation via progesterone and [pH]I, and 
activation of sperm neck Ca2+ stores via 4-AP, on induction of hyperactivation and 
penetration of viscous environments.  Both calcium stores at the acrosome and the 
neck/midpiece are activated respectively (Alasmari et al., 2013b).   
25 
 
for the fertility status of sperm? And if so, should this procedure be included in the SA 
performed prior to treatment, to inform treatment choice? 
Two studies in 1993 and 1994 looked at human sperm Ca2+ response to progesterone, 
comparing results between normal males and teratozoospermic patients. Shimizu et al 
performed experiments on sperm cells incubated with Fura-2 dye, which were then 
treated with 1microgram/mL progesterone (Shimizu et al., 1993). Sperm from infertile 
males with a large number of morphologically abnormal forms elicited a lower Ca2+ 
peak when stimulated with progesterone compared to fertile controls. Oehninger et al 
(1994) also found that men with severe teratozoospermia (less than 14% normal 
forms) showed abnormal basal Ca2+ levels and an abnormal Ca2+ response when 
stimulated with progesterone (Oehninger et al., 1994).  
Falsetti et al (1993) also looked at the progesterone-stimulated Ca2+ increase and 
compared normozoospermic samples with oligozoospermic samples. Progesterone-
stimulated Ca2+ increase significantly correlated with sperm motility, concentration, 
and good morphology. However the Ca2+ increase seen in oligozoospermic patients 
after treatment with progesterone was significantly lower than normozoospermic 
subjects. The addition of progesterone was also able to increase the number of 
acrosome reacted sperm in the normozoospermic samples, however had no significant 
effect on the oligozoospermic samples. Thus, the reduced ability of oligozoospermic 
samples to respond to stimuli such as progesterone may be the underlying factor 
causing their infertility. Significantly, there was also no discernible calcium response 
to progesterone in 4 of the 17 (24%) oligozoospermic patients (Falsetti et al., 1993).  
Krausz et al (1995) compared Ca2+ response to progesterone in groups of low 
fertilisation (<50%) and high fertilisation (>50%). It was found that in patients with 
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fertilisation rates lower than 50%, the percentage of [Ca2+]i and percentage of sperm 
that underwent acrosome reaction when treated with progesterone were significantly 
lower than in those patients who achieved >50% fertilisation rate. In 4 out of 5 cases 
of fertilisation failure, no increase in Ca2+ or acrosome was seen. The conclusions from 
this study were that Ca2+ increase and acrosome reaction in response to treatment with 
progesterone can have a good predictive value of fertilisation outcome (Krausz et al., 
1995).  
Espino et al showed that asthenozoospermic patients had lower Ca2+ responses to 
progesterone, and progesterone was not able to elicit an increase in progressive 
motility in these cells, compared with males with normospermia. Blockade of the 
progesterone receptor by c262 antibody or by RU-38486, a progesterone receptor 
antagonist, also reduced Ca2+ mobilization initiated by progesterone (Espino et al., 
2009).  
Meseguer et al found that there was a statistically significant difference in [Ca2+]i 
between fertile and infertile males (Meseguer et al., 2004a). Furthermore, 5 years later, 
Huo et al also found that infertile patients have lower basal Ca2+ than fertile patients 
(Huo et al., 2009). Infertile patients have no significant difference between basal and 
peak Ca2+ levels as determined by confocal microscopy. This leads to the question of 
whether a defect of the sperm progesterone receptor was present in this subsection of 
infertile patients (Huo et al., 2009). 
It has been previously shown that while IVF patients and donors show similar Ca2+ 
responses to progesterone, the Ca2+ response to progesterone for ICSI patients was 
significantly lower (Alasmari et al., 2013a). This difference in Ca2+ response between 
the two groups may have a significant basis for the infertility observed in the patient, 
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as progesterone and Ca2+ are known to be integral for sperm motility and therefore 
will have a knock-on effect on the sperm’s fertility. The molecular reason behind their 
failed Ca2+ response is as of yet unknown, however it is accepted that progesterone is 
able to regulate CatSper, initiating Ca2+ influx into the cell, and the generation of 
hyperactivated movement. Absence of CatSper and therefore lack of entry of Ca2+ into 
the cell results in inability to produce hyperactivated movements of the flagellum in 
mice (Quill et al., 2003). Therefore it is important to recognise Ca2+ response to 
progesterone as an indicator of success or failure during use of ART, as it could 
indicate the function or dysfunction of CatSper within that sample. 
Previous studies showing a reduced Ca2+ response to progesterone in infertile patients 
when compared with normozoospermic donors should be treated with caution. It is 
currently impossible to measure a cell’s Ca2+ response to progesterone and then use 
the same cell to fertilise an oocyte, therefore we cannot truly know whether these cells 
that respond well are indeed the most fertile. Furthermore, the technique for measuring 
[Ca2+]i
 measures an average fluorescence emitted by the bound/unbound Ca2+ when 
treated with progesterone. The data cannot distinguish the single cell’s response to 
progesterone: whether some respond well and others not at all, or whether all cells 
respond but at a lower level in patient samples. Single cell Ca2+ imaging is required to 
inform whether all or a proportion of cells are responsive to progesterone, and whether 
this changes between normozoospermic and infertile patient samples.  
 
1.10 The impact of cryopreservation on sperm function 
The Italian scientist Lazzaro Spallanzani (1729-1799) first described the storage of 
human semen in snow in 1776, reporting that the sperm became motionless when 
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exposed to cold temperatures (Ombelet and Van Robays, 2015). Semen 
cryopreservation and thaw for artificial insemination was developed for commercial 
use in domestic animals, particularly in the dairy industry, as a method of enabling 
long-term/indefinite storage. Cryopreservation was noted for arresting metabolic 
cellular processes and allowing long-distance transport for semen samples from the 
most prolific breeders, or “stud” animals, to ensure continuation of their superior 
genetic material (Verberckmoes et al., 2004). 
In humans, semen cryopreservation has been utilised in the ART repertoire since the 
1960’s (Sherman, 1973). The longest duration between semen being cryopreserved 
and achievement of pregnancy utilizing ICSI is 40 years (Szell et al., 2013), with 
further reports of pregnancies from IUI using sperm thawed after 28 years after 
cryopreservation (Feldschuh et al., 2005) and from ICSI 21 years after 
cryopreservation (Horne et al., 2004). Clinically, cryopreservation of semen is 
routinely utilised for fertility preservation under a variety of different circumstances. 
These circumstances include but are not limited to: pre-chemotherapy or radiotherapy, 
prior to surgery of the male genitalia (vasectomy, orchiectomy or gender 
reassignment), for quarantine of donor sperm and throughout IUI treatment cycles of 
multiple recipient patients, for storage pre- or posthumously, for males in dangerous 
professions such as the armed forces or working offshore, for treatment back-up if the 
sample on the day is expected to be poor, if the male partner is anticipated to not be 
present, or if the male partner experiences difficulty in producing a sample (Anger et 
al., 2003). The regular use of frozen-thawed sperm in IUI, IVF and ICSI evidently 
requires the best post-thaw recovery possible, in order to improve treatment success 
rates.  
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It has been well documented that cryopreservation of sperm results in a dramatic 
reduction in concentration and motility of the thawed samples, due to osmotic shock 
from the use of high osmolality cryoprotectants and membrane damage from 
intracellular ice crystal formation the freeze-thaw process (Boitrelle et al., 2012). 
Furthermore, sperm mitochondrial function, ability to acrosome react in response to 
progesterone and morphology were similarly shown to be reduced after 
cryopreservation (Rossato et al., 2000, O'Connell et al., 2002). However the impact of 
post-thaw sperm function on fertilisation is controversial; while some believe 
cryopreservation has no negative effect on fertilisation (Ashkenazi et al., 1991, Lansac 
et al., 1997, Marcus-Braun et al., 2004), others hold the opposite view (Smith et al., 
1981, Subak et al., 1992, Di Santo et al., 2012). Cryopreservation has previously been 
shown to significantly negatively affect phospholipase Cζ (PLCζ) concentrations in 
human sperm (Kashir et al., 2011), however little is known about the effect of 
cryopreservation of semen on human sperm calcium regulation. 
In 1994, it was identified that the intracellular calcium concentration in human sperm 
was increased following cryopreservation, and that around half the cryopreserved 
samples failed to produce an intracellular calcium response to progesterone compared 
to all of the fresh samples (McLaughlin and Ford, 1994). It was concluded that 
cryopreservation may result in the loss of the progesterone receptor due to cell 
membrane damage. It is now understood that the progesterone receptor is CatSper 
(Lishko et al., 2011, Strunker et al., 2011), and that CatSper integrity is required for 
fertilisation (Zhang et al., 2007, Avenarius et al., 2009, Smith et al., 2013). 
Furthermore, lack of CatSper 1 protein expression, and therefore functional channel 
activity, is correlated with asthenozoospermia in male infertility (Tamburrino et al., 
2015) (Tamburrino et al., 2015). The effect of cryopreservation on human sperm 
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function, and in turn the effect on calcium regulation with particular reference to the 
CatSper channel, clearly requires further investigation. 
 
1.11 Aims 
Many studies have investigated the importance of Ca2+ signalling in response to 
progesterone and its impact on male infertility. However there are still gaps in our 
knowledge about CatSper, most importantly its role in male factor infertility. There 
are several key points that the experiments used in this study are going to address. 
Firstly, donor sperm with normal WHO parameters for semen (concentration, total 
concentration and motility) will be analysed for Ca2+ response to progesterone, 
hyperactivation with 4-AP, progesterone and TMA, and ability to penetrate mucus via 
the viscous media penetration test. Patient samples for IVF and ICSI will also be 
subjected to these tests.  
This thesis will focus on the Ca2+ response to progesterone of sperm, more 
specifically:  
 Investigation into incidence of calcium pathway defects in IVF patients 
and donors.  
 To determine correlation between calcium pathway defects and 
fertilisation rate in IVF. 
 Investigation into incidence of calcium pathway defects in patients who 
have undergone a cycle of IVF with low/failed fertilisation. 
 To examine the effect of cryopreservation on CatSper channel 
function. 
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 Developing single cell Ca2+ imaging as a novel technique for 
investigating Ca2+ response to progesterone in IVF/ICSI patient 
samples. 
 
1.12 Hypothesis 
We hypothesise that the proportion of calcium pathway defects will be significantly 
elevated in patients undergoing assisted conception compared with donors, and this is 
a prominent factor affecting their likelihood of successful treatment outcome.  
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Chapter 2 
Materials and Methods 
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2.1 Materials 
Commercially available Quinn’s Advantage Fertilization (HTF) Media (SAGE 
CooperSurgical, Origio, catalogue number ART-1021) was used as capacitating media 
for IVF patients in the ACU, and donors in the research laboratory. Serum protein 
substitute (SPS: SAGE CooperSurgical, Origio, catalogue number ART-3010-1, until 
the end of December 2013) or human serum albumin (HSA: SAGE CooperSurgical, 
Origio, catalogue number ART-3001-5, from January 1st 2014) was added to HTF 
media in a 1 in 10 dilution, to a final protein concentration of 5mg/ml or 3mg/ml 
respectively. Quinn’s Sperm Washing Media (SAGE CooperSurgical Origio, 
catalogue number ART-1006) was used as non-capacitating media for ICSI samples. 
Components of these media are found in Appendix Table 2.1.  
STF (synthetic tubal fluid) media based on Lishko et al, 2011, was used as a non-
capacitating, phenol red free, protein-free media for re-suspending samples prior to 
calcium imaging in the FLUOstar Omega plate reader to reduce background 
fluorescence. Ionic concentrations were as follows (in mM): NaCl (98), KCl (4.7), 
MgSO4 (0.2), CaCl2 (2), HEPES (21), lactic acid (21), glucose (3) and Na pyruvate 
(0.3). pH was adjusted to 7.4 using 10M NaOH, with osmolality between 280-
320mosmol. Components of this media are found in Appendix Table 2.1.  
Stock reagents were dissolved in solvents such as dimethyl sulfoxide (DMSO, 
catalogue number D8418, Sigma Aldrich, UK), ethanol and deionized water. Stocks 
were created so that the concentration of solvent present in the final sperm suspension 
was equal to or less than 1%, which has been shown previously to not affect sperm 
acrosome reaction or  capacitation (de Lamirande and Gagnon, 2002). 
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Stock progesterone (catalogue number P8783, Sigma Aldrich, UK) was dissolved in 
ethanol and stored in the freezer at -20°C at a concentration of 36mM. Stock 
progesterone was diluted in HTF before being added to sperm suspension for 
hyperactivation or calcium screening experiments, to make a final concentration of 
3.6µM progesterone, similar to the concentration used previously (Meizel et al., 1997). 
The two-step dilution was performed to ensure ethanol concentration was just 0.01%. 
Concentrations of progesterone above 2μM were also found by Strunker et al to 
achieve maximal plateau phase calcium response to progesterone (Strunker et al., 
2011). Diluted progesterone made fresh daily, and was warmed to room temperature 
before use. 
Stock trimethylamine (TMA) was used as an intracellular alkylating agent (Cross and 
Razy-Faulkner, 1997), and was prepared by dissolving trimethylamine hydrochloride 
(catalogue number T72761, Sigma Aldrich, UK, formula weight 91.15g mol-1) in 
DMSO at a 1M concentration, to be used in a 1:100 dilution for a 10mM final 
concentration. 10mM concentration was used as it was previously shown to be able to 
induce stable intracellular alkalinisation in bovine sperm (Galantino-Homer et al., 
2004). Stock solutions were made monthly, kept in the fridge (5°C), and warmed to 
room temperature before use.  
4-aminopyridine (4-AP, catalogue number 275875, Sigma Aldrich, UK) was prepared 
in deionized water to make 200mM stock concentration. It was added to the sperm in 
a 1:100 dilution to make a final concentration of 2mM; this concentration had been 
previously described as sufficient to instigate hyperactivated motility in human sperm 
(Gu et al., 2004). 4-AP stock was kept in the fridge (5°C) and warmed to room 
temperature before use.  
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Fura-2 acetoxymethyl ester stock (Fura-2/AM, catalogue number F-1221, Molecular 
Probes, Eugene Oregon, USA) was dissolved in DMSO and kept in the freezer at -
20°C at a stock concentration of 500µM. 1µl of stock was added to 500µl of sperm 
suspension, for a final concentration of 1µM as previously described (Alasmari et al., 
2013a). These steps were all carried out in the dark, to avoid photobleaching (Becker 
and Fay, 1987), and was warmed to room temperature before use.  
Pluronic acid (Pluronic® F-127, catalogue number P2443, Sigma Aldrich, UK), a 
surfactant, was added to STF media (based on Lishko et al, 2011, a non-capacitating 
media free of BSA) at a 1%w/v solution, and was used to aid dye loading into the 
cells. This was made daily, and used at a final concentration of 0.05% as previously 
described (Strunker et al., 2011).  
Stock manganese chloride (catalogue number 244589, Sigma Aldrich, UK) was 
dissolved in deionized water to a stock concentration of 100mM. 5µl was added to a 
50µl well of sperm suspension in a 96 well plate, to make a final concentration of 
9.1mM. This step was performed as previously described by Jörs et al in order to 
quench Fura-2/AM fluorescence, in order to obtain the background level of 
fluorescence (Jörs et al., 2006). 
Fluo-4/AM was the single wavelength dye used for single cell imaging studies as 
described previously (Wood et al., 2003), with the aim of quantifying intracellular 
calcium changes. The dye was dissolved in DMSO and stored at -20°C at a stock 
concentration of 1mM. Fluo-4/AM was used at a final concentration of 1µM.  
Stock Ca2+ ionophore A23187 (catalogue number C7522, Sigma Aldrich, UK) was 
dissolved in DMSO to a stock concentration of 5mM. Stock solution was dissolved 
1:5 with HTF before use, then used at 100µM final concentration.  
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2.2 Ethical Approval and recruitment of patients/donors 
Patients attending for IVF or ICSI treatment, or recalled for follow-up appointments 
with a consultant after a cycle of failed/low fertilisation, were recruited from the 
Assisted Conception Unit (ACU) Ward 35, Ninewells Hospital, to provide surplus 
samples to research, under the HFEA (Human Fertilisation and Embryology 
Authority) Code of Practice version 8 and ethical approval from Tayside Committee 
of Medical Research Ethics B (13/ES/0091) as previously described (Tardif et al., 
2014). Patients were given information about the research projects carried out, and 
were given opportunities to ask questions and were advised that they could revoke 
their consent to research at any point. Patients were also asked if they were willing to 
be approached regarding the production of further samples for research. All patients 
willing to participate in research were allocated a research number to ensure 
anonymity: this was in the format of R0000 where the letter R was followed by 4 
numbers. Numbers were assigned in ascending order chronologically. 
Healthy young males were recruited by the research team under ethical approval 
08/S1402/6 as donors (typically students) randomly selected from the population, with 
no known underlying fertility problems. During the initial consultation, potential 
donors were required to fill out questionnaires relating to fertile status (contribution to 
a pregnancy), use of drugs/medications, and other relevant sexual history. Potential 
donors then produced one sample for assessment, to ensure they met/surpassed WHO 
2010 criteria for semen volume, sperm concentration and motility. After acceptance, 
donors were allocated a 3 digit code to provide anonymity, and all identifying 
information was only accessible by members of the laboratory team. 
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2.3 Donor Semen Samples – Production, Analysis and Preparation 
Donors were requested to abstain for between 2 and 7 full days before production and 
to produce a sample by masturbation into a sterile container off-site (60ml Sterilin™ 
Thermo Scientific, polystyrene container with plastic lid). Donors were asked to bring 
their samples to Ninewells Hospital within one hour of production, and were requested 
to not expose the sample to any extremes of temperature, to note on the laboratory 
form if they had missed any fraction of the ejaculate and how many days abstinence 
had been observed (Bjorndahl et al., 2016). All donor sperm samples used in this study 
exceeded 2010 WHO criteria 5th centile for semen volume, sperm total/progressive 
motility and sperm concentration. The semen was allowed to liquefy for at least 15 
minutes at 37°C, and a raw semen analysis using CASA (computer assisted sperm 
analysis) was undertaken within an hour of the time of ejaculation on a Hamilton 
Thorne CEROS microscope (Beverly, MA, USA) under phase contrast. Parameters 
were analysed as described in Appendix Table 2.2. Donors were compensated a fixed 
sum of £15 per donation. 
Raw semen analysis was performed by CASA on donor samples according to WHO 
guidelines (WHO, 2010). Pre-warmed 2X-Cel chambers (Dual Sided Sperm Analysis 
Chamber, Hamilton Thorne Biosciences, Beverley, MA, USA) slides were loaded 
with 4µl of semen, and were covered with a pre-warmed coverslip to a set depth of 
20µM. These were placed on a heated stage (37°C) to be analysed by a Hamilton 
Thorne CEROS machine attached to an Olympus CX41 microscope (Olympus 
Corporation, Tokyo, Japan). Semen with a high sperm concentration (>100million/ml) 
was diluted with non-capacitating buffer in order to more accurately assess the 
concentration of sperm present. Concentrations of sperm per ml of semen, total 
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motility (%), progressive (% of cells which VAP>25µM/sec, STR>80%) and rapid 
motility (%) of sperm were analysed using CASA, with a negative phase contrast 
image at 100x final magnification. Other sperm motility parameters such as ALH, 
VCL, VSL, VAP, BCF, LIN and STR were also recorded (see Appendix Table 2.2). 
To obtain the most mature and morphologically normal sperm from raw semen, sperm 
were separated from the seminal plasma by discontinuous density gradient 
centrifugation. 90% Percoll (catalogue number P1644, Sigma Aldrich, UK) was 
prepared using a 1:9 ratio of 10X STF (based on Lishko et al, 2011) to 100% Percoll. 
40% and 80% Percoll were prepared by diluting the 90% Percoll with SW media 
(Mortimer and Mortimer, 2013). Up to 2ml of raw semen was gently layered on top 
of 1.5ml 40% Percoll, underlaid by 1.5ml 80% Percoll. The column was then 
centrifuged at 300g for 20 minutes in order to separate the sperm according to their 
density. The supernatant consisting of seminal plasma, bacteria, white blood cells and 
other debris was discarded. The pellet of highest quality (with the greatest density and 
compaction of DNA) was separated by the 80% fraction, as mature normal sperm have 
a density of >1.12g/ml, and the specific gravity of the 80% fraction is 1.10g/ml. The 
immature and morphologically abnormal sperm have densities less than 1.10g/ml, 
therefore are unable to penetrate the 80% layer, and were retained by the 40% layer 
(Mortimer and Mortimer, 2013). The seminal plasma and 40% layer were removed by 
sterile plastic Pasteur pipettes (Sigma Aldrich, UK), leaving just the 80% layer plus 
the pellet. This serves to reduce contamination of the pellet with seminal plasma 
containing bacteria or other cell debris, or sperm from the 40% layer. The pellet was 
removed from the tube and was washed in 4ml SW media by centrifugation at 500g 
for 10 minutes. The supernatant was removed and the pellet resuspended in HTF 
media and incubated at 37°C 5% CO2 for a minimum of 2 hours.  
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2.4 IVF and ICSI patient Semen Samples – Production, Analysis and 
Preparation 
In the ACU, IVF (meeting WHO (2010) normal semen analysis criteria and exceeding 
1x106 progressively motile sperm after preparation) and ICSI patients (those not 
meeting IVF criteria, or with other clinical indications) produced a fresh semen sample 
typically on-site on the morning of their procedure into a sterile Starstedt 100ml 
container. Semen was allowed to liquefy for a minimum of 15minutes in an incubator 
at 37°C. Raw semen analysis for patient samples was carried out in the clinic by an 
embryologist or laboratory technologist, using a haemocytometer for cell counts and 
a digital cell counter for motility analysis. Sperm were counted as being static (D, non-
motile), slow (C, motile but not progressive), progressive (B) or rapid (A, movement 
> 25µm/sec). The sperm were then prepared by density gradient centrifugation using 
PureSperm® (catalogue number P5100, NidaCon International, AB Sweden) buffered 
with SW media. The 80% pellet was then washed using SW media and centrifuging 
500g for 10 minutes, before being resuspended in bicarbonate-buffered Quinn’s 
Advantage Fertilization (HTF) Media supplemented with 10% SPS/HSA and gassed 
with 6% CO2 for 20 seconds for IVF samples. This HTF media was maintained in an 
incubator at 37°C, 6% CO2 overnight previous to sperm preparation for treatment. 
Samples were resuspended in non-capacitating HEPES-buffered Quinn’s Advantage 
Sperm Washing Media (SW) for ICSI procedures. Prepared samples were left at room 
temperature for up to 4 hours for ICSI, whereas in IVF, samples were maintained at 
room temperature for around three hours, depending on the time of insemination, 
before being placed into the CO2 incubator to capacitate for one hour before 
insemination occurs. After insemination by IVF or ICSI, patient samples surplus to 
treatment requirements were retrieved for research purposes. 
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2.5 Screening for hyperactivation 
A control reading of hyperactivation was obtained by acquisition of four fields of view 
of untreated sperm on the CASA, having been resuspended in HTF media and placed 
under capacitating conditions for 2 hours minimum. The drugs 4-amino pyridine (4-
AP, final concentration 2mM), progesterone (final concentration 3.6µM) and 
trimethylamine hydrochloride (TMA, final concentration 10mM) were added to 100µl 
aliquots of sperm, and again four fields of view were analysed for hyperactivation at 
t0 after the drug was added. A minimum of 200 sperm were analysed per treatment, 
as per WHO guidelines for use of CASA (2010). The vehicle controls for these 
compounds (water, ethanol and DMSO for 4-AP, progesterone and TMA respectively) 
were also analysed to ensure that the vehicle was not having a detrimental effect on 
sperm motility.  
2.5.1 Donor hyperactivation in response to progesterone, TMA and 4-AP and their 
respective vehicles ethanol, DMSO and water 
Donor sperm were subjected to treatment with final concentrations of 3.6µM 
progesterone, 10mM TMA and 2mM 4-AP. Motility was analysed as soon as cessation 
of drifting on the slides had occurred (~30 seconds after compound addition), in order 
to visualise whether the calcium response to progesterone which immediately after 
addition and peaks after around 75 seconds, and lasts for a total of around 150-200 
seconds, is correlated with any motility parameter. Furthermore as the HTF media 
used was bicarbonate-buffered, it was imperative to use the shortest time possible 
outside of the CO2 incubator, in order to maintain the pH of the solution. CASA 
software was used to analyse the motility parameters, including percentage of sperm 
showing hyperactivated movement, with the requirements of curvilinear velocity 
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(VCL)>150, linearity (LIN)<50 and amplitude of lateral head displacement (ALH)>7 
(Mortimer et al., 1998). Other sperm motility parameters compared between 
compound treatment groups and also between patients and donors, were VAP, VSL, 
VCL, ALH, BCF, STR, LIN, % motile, % rapid, % progressive and % hyperactivated 
(as described in Appendix Table 2.2). Vehicle controls (1% water control for 4-AP, 
1% DMSO control for TMA and 0.01% ethanol control for progesterone) had no 
significant effect on any motility parameter studied (Figure 2.1). 
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Figure 2.1 Effect of vehicle on motility. Motility in donor samples was not 
significantly affected in response to vehicle controls water, DMSO and EtOH. Bars 
represent average donor response ±SEM, n=30. 
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2.6 Calcium response to progesterone – FLUOstar Omega microplate 
method 
2.6.1 Number of sperm per well 
In previous studies, a minimum of 2 million sperm per well was found to be necessary 
for FLUOstar Omega calcium response to progesterone assessment (Alasmari et al., 
2013b). To determine the number of sperm per well necessary for the present study, 
donor samples were adjusted to varying concentrations: 0.675 million, 0.125 million, 
0.25 million, 0.5 million, 1 million, 2 million and 4 million. The response to 
progesterone was undetectable at 0.675 million cells. The response was difficult to 
detect with a low signal to noise ratio in 0.125 and 0.25 million cells. The signal was 
visible and quantifiable at 0.5 million, 1 million, 2 million and 4 million cells as 
displayed in Figure 2.2. However due to residual noise in the signal from 0.5, 1 and 2 
million cells, 4 million cells was chosen to be the final working number of cells in the 
well. This cell count enabled a smoother curve and therefore a more accurate 
identification of the peak calcium response to progesterone. 
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2.6.2 Capacitated versus non-capacitated sperm calcium response to progesterone. 
All samples were capacitated for a minimum of two hours before use, unless otherwise 
stated, due to the previously reported potentiation of the calcium response to 
progesterone under capacitating conditions (Baldi et al., 1991, Bedu-Addo et al., 
2005).  
 
 
Figure 2.2 Calculation of numbers of sperm used for calcium response to 
progesterone. 0.5 million, 1 million, 2 million and 4 million sperm are able to 
produce a calcium response to progesterone however the signal to noise ratio was 
smallest when using 4 million cells (0.5 million n=7, 1 million n=8, 2 million n=6 
and 4 million n=6). Arrow shows the addition of progesterone to a final 
concentration of 3.6µM. Graph baselines are staggered for clearer visualisation of 
the traces. 
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2.6.3 FLUOstar Omega method 
Four million cells were prepared in 500µl HTF Media. 1µM Fura-2/AM and 0.05% 
Pluronic acid F127 were added for one hour at 37°C in the presence of 6% CO2 to 
ensure continuing capacitation and bicarbonate buffered pH stability. The samples 
were centrifuged at 500g for 10 minutes to remove excess dye, before the pellet was 
removed and resuspended in 500µl STF media lacking BSA. A further centrifugation 
step at 500g for 5 minutes was performed, where again afterwards the supernatant was 
removed and replaced with 500µl STF media lacking BSA. After a further 
centrifugation step at 500g, the supernatant was then removed and the pellet 
resuspended in 45µl STF media, and was placed in one well of a 96-well black half-
volume 4.5mm diameter 190μl volume Greiner plate. The FLUOstar Omega (BMG 
Labtech Offenburg, Germany) microplate reader machine was used to calculate the 
calcium response to progesterone. Progesterone was added at 3.6µM final 
concentration after 20 readings of baseline bound and unbound calcium (100 seconds). 
The calcium response to progesterone was observed by alternating fluorescence 
excitation at 380 and 340 nm, with emission at 520nm, and a normalised ratio of 
340/380nm was used to obtain graphs. Manganese chloride was added at a final 
concentration of 9.1mM after the secondary progesterone response had plateaued in 
order to quench all Fura-2 fluorescent dye. This was then used to calculate the 
background level of fluorescence, which was subtracted from respective 340 or 380nm 
fluorescence intensities. 
2.6.4 Vehicle control 
In order to ascertain that progesterone itself was causing the rise in intracellular 
calcium, a vehicle control consisting of 0.01% ethanol in STF was used in the case of 
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three donors and the effect on calcium uptake was monitored. This was run in parallel 
with progesterone treated cells. As seen in Figure 2.3, the mean 380:340 peak ratio 
after vehicle addition was below the 5th centile cut-off for donor samples, and 
furthermore was significantly reduced at just 41% of the delta response obtained from 
progesterone addition. Presence of residual progesterone within the system could not 
be excluded. Thus it was concluded progesterone, and not vehicle, was significantly 
stimulating the increase in intracellular calcium. 
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2.6.5 Donor inter-ejaculate variation 
Individual donors were asked to provide multiple samples for analysis on separate 
occasions. Due to the variety in sperm concentration and sperm motility between 
ejaculates, it was important to decide whether sperm donors should be treated 
individually (multiple ejaculates pooled together), or if each individual ejaculate 
should be considered separately (result per ejaculate, regardless of donor origin). 
Figure 2.3 Addition of vehicle led to a significantly reduced calcium response. 
This was below the 5th centile cut-off value for donor samples, n=3 paired samples. 
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Thus, multiple ejaculates from one specific donor were analysed for their post-
preparation calcium response to progesterone. It was observed that there was a 
significant difference in the peak calcium response to progesterone when comparing 
results from different ejaculates from the same donor (an example of 4 ejaculates from 
1 donor is visualised in Figure 2.4). Thus, calcium responses to progesterone from 
ejaculates from the same donor were classified as separate data, due to the high inter-
ejaculate variability observed. 
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2.6.6 Defining cut-off values for poor responders 
The frequency distributions for delta calcium response to progesterone were created 
for both IVF patients and donors (Figure 2.5). “Bin center” indicates the middle value 
Figure 2.4 Variation in ejaculate response from a single donor. Donor inter-
ejaculation variation in the peak calcium response to progesterone was sufficient 
enough to warrant treating each ejaculate as separate entities. The graph shows four 
different samples from the same donor. The arrow signifies addition of 
progesterone. 
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of the bin, or group of values: i.e. bin center of the values falling between 0.1-0.3 is 
0.2.  The cut-off value for poor responders was defined as being any delta value below 
the fifth centile for donors. This was calculated in Excel using the PERCENTILE 
function as being anything below a delta value of 0.64.  
Three of the 44 donor samples examined had delta values below 0.64 (6.8%). 
Frequency distribution of delta calcium
 response to progesterone
0.2 1.0 1.8 2.6 3.4 4.2 5.0
0
5
10
15
20
IVF
DONOR
Bin Center
F
re
q
u
e
n
c
y
 
 
  
Figure 2.5 Frequency distribution of delta calcium response to progesterone. 
The histogram of delta calcium response to progesterone demonstrates that the 
frequency distribution of IVF patients and donors is similar, and normally 
distributed according to Kolmogorov-Smirnov normality test. The dotted red line 
represents the 5th centile. IVF n=129, donor n=44 ejaculates. 
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2.7 The Viscous Media Penetration Test 
Methylcellulose, a synthetic cervical mucus solution (Ivic et al., 2002), was made by 
the addition of 10mg/ml of methylcellulose (catalogue number M0512, Sigma 
Aldrich, UK) to HTF media supplemented with 10% SPS or HSA as a protein source. 
Capillary tubes (Vitrotubes™, Rectangle Capillaries 0.4mm x 400mm, catalogue 
number 2540-050, VitroCom, New Jersey, USA) were inserted into the pre-warmed 
methylcellulose, incubated in 5% CO2, which was then drawn into the tube by 
capillary action. The top end of the tube was sealed with Plasticine to prevent further 
capillary action once inserted into the sperm suspension. Tubes were labelled with the 
donor/patient code and treatment group, before being added to 100µl aliquots of sperm 
suspension in HTF media, and were maintained for an hour in conditions supporting 
capacitation, at 37°C and 5% CO2. Sperm suspensions were either maintained 
untreated, treated with 0.01% ethanol as a vehicle control, or were treated with a final 
concentration of 3.6µM progesterone, to observe the effect of progesterone on 
penetrating ability of sperm. 
After 1 hour, excess sperm were wiped off the tube and the open end was sealed with 
Plasticine. Marks were drawn on to the tube at 1cm from the end inserted into the 
sperm sample. 1cm was chosen as the distance measured as is the most informative 
and clinically relevant marker, as the hyaluronan matrix holding the cumulus cells 
does not exceed 1cm in distance from the oocyte. The tube was analysed for sperm 
penetration under 200x magnification, and CASA was used to analyse 4 fields of view 
at each distance measured, with three measures of depth adjusted manually for each 
field of view, in order to account for the depth of the tube. Average numbers of sperm 
at each centimetre mark for each treatment were recorded and compared. Motility 
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patterns for sperm swimming within the capillary tube were recorded by CASA, and 
compared between treatment groups (Chapter 3). 
 
2.8 Cryopreservation and Thawing of Donor Samples 
Semen was cryopreserved within one hour of ejaculation, after liquefaction was 
achieved. Prior to cryopreservation, both the cryoprotectant and liquefied semen were 
equilibrated to room temperature (21°C). An equal volume of cryoprotectant (Sperm 
Freezing Media, catalogue number 10670010, Origio, Medicult Media, Denmark) was 
added to the raw semen dropwise (~50µl) in a 50ml Falcon tube over a minimum of a 
5 minute period, and was mixed continuously to avoid hypoosmotic shock (Stanic et 
al., 2000). 1ml of 1:1 semen:cryoprotectant was loaded per cryovial, and labelled with 
the donor number and date. The sample was placed in the fridge for 30 minutes before 
placing in vapour phase of the liquid nitrogen storage facility. The sample was 
maintained in vapour phase until use.  
To thaw the sample, the cryovial was submerged in water at 30°C until thawed. A 
Pasteur pipette was used to place the whole thawed sample into a 50ml Falcon tube. 
The same volume of SW media as semen plus cryoprotectant was added dropwise, 
and mixed continuously to avoid osmotic shock, at room temperature for a minimum 
of 5min. Once mixed, up to 2ml of the sample was prepared over each 40%/80% 
Percoll gradient, and a wash step was performed as described in section 2.5.   
This protocol was in accordance with the standard operating procedure used by 
Ninewells Assisted Conception Unit for semen cryopreservation and thaw. 
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2.9 Single cell calcium imaging. 
Both IVF/ICSI patient and donor spermatozoa were subjected to single cell calcium 
imaging after treatment with progesterone. Donor samples were also investigated 
using 0.01% ethanol as a vehicle control. The spermatozoa were prepared by density 
gradient centrifugation and a wash step as described previously (Section 2.3). 
Following a minimum of 2 hours capacitation (excluding ICSI samples which 
remained non-capacitated), the spermatozoa were incubated with 1μM Fluo-4/AM 
(Shahar et al., 2011), for 30 minutes at 37°C, 5% CO2. The sample was then 
centrifuged at 100g for 5 minutes to obtain a loose pellet. The supernatant with excess 
dye was removed and the pellet was resuspended in 100μl of fertilisation (HTF) media 
lacking HSA protein source, to allow for better cell adhesion to the coverslip.  
100μl of 0.1% poly-D-lysine solution in HTF lacking HSA was pipetted onto the 
centre of a 24x50mm microscope cover glass slide and allowed to adhere at room 
temperature for 20 minutes. The surplus poly-D-lysine solution was removed. 45μl of 
sperm solution was added directly to the poly-D-lysine treated area, and incubated at 
room temperature for 10 minutes to promote settling and adhesion of the spermatozoa 
to the coverslip. 
The coverslip was visualised on a Nikon Eclipse TE2000 microscope under 400X total 
magnification with oil immersion. Cell density was adjusted to around 200 sperm per 
field of view by dilution of the sperm pellet within the Eppendorf with HTF lacking 
HSA. The computer program MetaFluor (Molecular Devices, CA, USA) was used to 
analyse data. Regions of interest were drawn around each cell either manually or via 
the computer program, incorporating the spermatozoon head and midpiece. Each ROI 
was inspected for accuracy of spermatozoa head and midpiece selection and 
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incorporation, and were de-selected if cells moved into or out of the ROI during the 
acquisition. Images were acquired after a time lapse of 100 milliseconds, with a 
duration of exposure of 40 milliseconds. 100 intervals (44 seconds) of basal recordings 
were collected before the addition of final concentration 3.6µM progesterone. 
Following a further 150 intervals (66 seconds), a final concentration of 100µM 
calcium ionophore A23187 was added for maximum fluorescence intensity, and 
following 100 intervals (44 seconds), 45mM Ca2+ chelating agent EGTA (ethylene 
glycol tetraacetic acid) for minimum fluorescence intensity. After acquisition, an ROI 
was selected that did not contain any spermatozoa to detect background levels of 
fluorescence. Data was exported to EXCEL for background correction, normalisation 
and determination of response to progesterone. 
Background correction was performed by taking the fluorescence intensity value at a 
given time point for an ROI placed manually over an area without any sperm present 
(Rx) and subtracting the value of the background fluorescence from the background 
detecting ROI for the given time point (BR). This was repeated for each cell observed. 
Normalisation of the data was performed by taking the average fluorescence intensity 
of the basal period of acquisition (Frest) and using the equation ((Rx – 
Frest)/Frest)*100). 
 
2.10 Whole cell patch clamp electrophysiology 
Electrophysiology was performed on some of the recalled patients by Dr Sean Brown 
and Dr Steven Mansell. The whole cell patch clamp protocol and solutions used were 
as previously published (Kirichok et al., 2006, Lishko et al., 2011, Mansell et al., 
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2014). The ramp protocol (-92 to 68mV at 1Hz) with Vm held at -92mV between test 
pulses under physiologically relevant standard bath conditions was used to investigate 
Na+, K+ and Cl- currents. The ramp protocol (-80 to 80mv) under Cs-based divalent 
free conditions with a holding potential of 0mV between pulses was used to investigate 
CatSper channel activity. 
A minimum of three ramps per cell was performed on all patient samples.  
 
2.11 IVF and ICSI fertilisation rate 
Fertilisation data was obtained from IVF patients with 4 or more MII oocytes. The 
morning after oocyte retrieval and insemination, oocytes were stripped and identified 
to be 1) immature at the GV (germinal vesicle) or MI (metaphase I) stage, 2) mature 
but unfertilised at the MII (metaphase II) stage of maturation, 3) fertilised normally or 
abnormally. In this study, normal fertilisation was confirmed with the presence of two 
pronuclei (2PN) and two polar bodies (2PB). Abnormal fertilisation was not counted 
in our data. Fertilisation was expressed as a percentage of the number of oocytes at 
MII that were successfully fertilised (Number of oocytes fertilized/number of MII 
oocytes collected). For ICSI samples, the premise was the same however maturity 
status was acknowledged prior to injection, and only MII oocytes were injected, 
therefore fertilisation rates were determined according to the number of oocytes 
injected. Failed fertilisation was defined as no normal fertilisation with 4 or more 
metaphase II oocytes present. Low fertilisation was defined as <25% of 4 or more 
metaphase II oocytes normally fertilised. 
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Fertilisation data was requested retrospectively in batches of approximately 20 
patients. The information was collected by a clinical support worker who un-blinded 
the research code, looked up the patient on the Assisted Conception Unit database and 
recorded the relevant information, and re-blinded the data before passing it to the 
research team, ensuring anonymity. 
 
2.12 Statistics  
The Kolmogorov-Smirnov test was used to analyse distribution of data, a P-value of 
P>0.05 was accepted as data being normally distributed. To compare normally 
distributed data, an independent samples two-tailed Student’s t-test or one-way 
ANOVA (analysis of variance) was used. Paired Student’s t-tests and Wilcoxon 
signed-rank tests were used as parametric and non-parametric tests respectively, where 
samples were paired. To compare non-parametric data, a Mann-Whitney or Kruskal-
Wallis test was used. Correlation analysis was performed to compare the relationship 
between normally distributed variables, with a Pearson product-moment correlation 
coefficient to analyse the goodness of fit. Spearman’s rank correlation coefficient was 
used to analyse the correlations between non-parametric data. 
Data was processed and statistically analysed in GraphPad Prism and Microsoft Excel. 
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Chapter 3 
Investigation into the incidence of calcium pathway defects in 
IVF patients and donors 
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3.1.1 Introduction 
Electrophysiological study of the CatSper channel by whole cell patch clamp 
technique is the gold standard for assessment of ion channel function (Kirichok et al., 
2006), however this technique is low-throughput with few cells able to be studied per 
sample, and relies on Cs+ based divalent free solutions rather than studying Ca2+. 
Therefore other methods must be used to indirectly assess CatSper function, and in 
the present study this is performed by using calcium response to progesterone as a 
surrogate. CatSper function is particularly relevant in patients undergoing IVF, where 
absence or dysfunction of the channel could result in inability to hyperactivate and 
therefore fertilise oocytes as is the case in mice (Quill et al., 2003). Although Alasmari 
et al (2013a) described that calcium regulation in human sperm differs between 
patients attending the assisted conception clinic in Ninewells Hospital, Dundee, and 
healthy donors randomly selected from the population, this study focused mainly on 
utilising agents such as 4-AP to modify sperm hyperactivated motility.  
Many studies have previously correlated the human sperm calcium response to 
progesterone with male infertility and therefore likelihood of success in IVF (as 
mentioned in section 1.9). However these studies have failed to identify the incidence 
of calcium pathway defects in response to progesterone in these patients. The 
molecular or physiological causes behind why these patients have a decreased calcium 
response to progesterone is also largely unknown, particularly as the majority of these 
studies were performed before the discovery that CatSper is potentiated by 
progesterone (Lishko et al., 2011, Strunker et al., 2011). 
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3.2 Aim 
This study aimed to use several different screening methods in order to elucidate the 
prevalence of defective calcium regulation and CatSper function in IVF patients and 
donors. These methods were: calcium response to progesterone, viscous media 
penetration test and induced hyperactivation with 4-AP.  
 
3.3 Hypothesis 
We hypothesized that there would be a greater incidence of calcium pathway defects 
in IVF patients when compared with donors, and furthermore poor response in any of 
these screening tests will be negatively correlated with sperm function, manifested in 
poorer fertilisation rates in IVF. 
 
3.4 Experimental design 
Donor and patient samples were prepared and capacitated as previously described. 
Samples were analysed for cell concentration and motility, before being split into 
portions for separate experiments, depending on cell number. The priority was to 
perform sperm calcium response to progesterone (IVF n=129 men, donor n=44 from 
30 men), followed by hyperactivation in response to stimulation by 4-AP (IVF n=68 
men, donor n=35 from 21 men) then progesterone (IVF n=48 men, donor n=34 from 
21 men), then TMA (IVF n=48 men, donor n=34 samples from 21 men), and lastly 
the role of progesterone on progression through viscous media (IVF n=17 men, donor 
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n=18 from 15 men). For the IVF patients, all screening results were correlated with 
fertilisation rate achieved in IVF. 
 
3.5 Results 
3.5.1 Donor initial semen parameters and IVF patient/donor prepared sperm 
parameters 
The average semen parameters for motility and concentration recorded for donors 
exceeded WHO 2010 criteria (mean concentration 119.9M/ml, mean total motile cells 
66.5%, mean progressively motile cells 38.2%, mean rapidly motile cells 56.2% (47 
ejaculates from 20 donors) Appendix Table 3.1).  
For samples prepared by density gradient centrifugation, the concentration of sperm 
in the donor samples was significantly higher than in the IVF samples (38.1M/ml 
versus 17.1M/ml, P= <0.0001, donor n=48 ejaculates from 20 donors, IVF n=68 men). 
Total motility (85.3% versus 79.5%, P=0.014), rapid motility (81.6% versus 74.9%, 
P=0.008) and hyperactive motility (18% versus 13.5%, P=0.021) parameters were all 
observed to be significantly higher in donor samples compared to IVF samples, 
however there was no difference observed in progressive motility (50.5% versus 
50.3%, P=0.95), as displayed in Appendix Table 3.2.   
 
3.5.2 IVF versus donor sperm calcium response to 3.6µM progesterone 
Analysis of the data for the basal calcium ratio, transient peak calcium and delta 
response (peak - basal) indicated that there was no significant difference between 
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values for IVF patients and donors in terms of the calcium response to progesterone, 
as displayed in Table 3.3, Figures 3.1 and 3.2. However there was a significant 
increment in the amplitude of the plateau phase for samples taken from IVF patients 
(Mann Whitney test, P=0.031), and the time taken to reach peak calcium response to 
progesterone was also increased by 2.02 seconds (Mann Whitney test, P=0.0004) for 
samples taken from IVF patients. Furthermore, the total duration of calcium response 
to progesterone was significantly increased in the IVF patient sample population 
(Students t test, unpaired samples P=0.029). 
Parameter Donor ±SD IVF ±SD P value 
Peak (340:380) 2.81 (0.7) 2.69 (0.8) 0.37 
Basal (340:380) 1.48 (0.2) 1.51 (0.3) 0.64 
Plateau (340:380) 1.39 (0.2) 1.45 (0.2) 0.031 
Time to peak (s) 8.1 (2.9) 10.12 (3.8) 0.0004 
Duration of peak (s) 61.81 (9.2) 65.97 (11.3) 0.029 
Delta (340:380) 1.81 (0.7) 1.78 (0.8) 0.78 
 
 
 
Table 3.3 Calcium response to progesterone kinetics for IVF patients and 
donors. Plateau calcium response, time to peak and duration of peak were all 
significantly increased in IVF samples, whereas peak calcium response, basal 
calcium, delta response were not significantly different between groups (n=129 for 
IVF samples, and n=44 samples from 30 donors). 
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Figure 3.1 IVF versus donor calcium response to progesterone. Mean calcium 
response to progesterone traces for IVF and donor samples are virtually 
indistinguishable from one another. Error bars represent SEM, arrow indicates time 
of 3.6µM final concentration progesterone addition. IVF sample n=129, donor 
n=44 samples from 30 men. 
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Figure 3.2 Graphical representation of data shown in Table 3.3. Plateau phase 
calcium response, time to and duration of peak were significantly increased for IVF 
patients when compared with donor controls. Peak, basal and delta calcium response 
to progesterone were not significantly different between groups. IVF sample n=129 
and donor sample n=44. 
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3.5.3 Hyperactivation in response to progesterone, TMA and 4-AP 
3.5.3.1 Donor versus IVF patient hyperactivation to 3.6µM progesterone, 10mM TMA 
and 2mM 4-AP 
Both donors and IVF patient samples were subjected to hyperactivation analysis under 
control conditions (IVF sample n=68, donor sample n=35), or after treatment with 
3.6µM progesterone (IVF sample n=48, donor sample n=34), 2mM 4-AP (IVF sample 
n=68, donor sample n=35) and 10mM TMA (IVF sample n=48, donor sample n=34), 
as shown in Figure 3.3. Under control conditions, and after 4-AP treatment, the mean 
donor hyperactivation response was significantly higher than the mean IVF patient 
hyperactivation response (P=0.021 and P=0.048 respectively). Neither TMA nor 
progesterone had any significant effect on enhancing hyperactive motility in either 
donor or IVF patient sperm samples (Figure 3.3).  
Total motility and rapid motility were not significantly altered after addition of any of 
the treatments, for either IVF patients or donors (Figure 3.3). As 4-AP was the only 
treatment to stimulate an effect on hyperactivated and progressive motility parameters, 
it will be discussed in further detail in section 3.4.2.  
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  Figure 3.3 Motility parameters after treatment with 2mM 4-AP, 3.6µM 
progesterone or 10mM TMA.  CASA motility analysis revealed that only 
treatment with 4-AP was able to significantly reduce progressive motility and 
increase hyperactivated motility. Treatment with progesterone and TMA revealed 
no significant change in motility in any parameter studied. Error bars represent 
SEM. 
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3.5.3.2 Hyperactivation and motility patterns in response to 2mM 4-AP treatment 
For both donors and IVF patients, 4-AP induced a rapid and significant average 
increase in hyperactivated motility (Figure 3.3). 4-AP also significantly increased the 
sperm VAP, VCL and ALH while decreasing BCF, STR, LIN and progressive motile 
%. Cells from 45 of the 68 (66%) IVF patients tested were able to significantly respond 
on addition of 4-AP, by displaying a significantly increased proportion of hyperactive 
cells. Cells from 2 of the 68 patients (3%) displayed a significant reduction in 
hyperactivation after 4-AP treatment, whereas cells from the remaining 21 patients 
(31%) showed no significant change in hyperactivation after treatment. For donors, 
sperm from 28 of the 35 samples (80%) were able to significantly respond to 4-AP in 
terms of increased hyperactivation. Cells from the remaining 7 samples (20%) were 
unable to significantly respond to 4-AP treatment. Significantly, there were no donor 
samples that exhibited a reduced hyperactivated motility in response to 4-AP, unlike 
their IVF patient counterparts. A histogram depicting the percent change in 
hyperactivation after 4-AP treatment for IVF patients is presented below (Figure 3.4) 
similarly to methods described previously (Alasmari et al., 2013b). 
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Figure 3.4 Histogram of proportional change (%) in hyperactivation in 
response to 2mM 4-AP treatment. Distributions of % change in hyperactivation 
between IVF patients and donors in response to 4-AP were not significantly 
different, although no donors exhibited a negative response to 4-AP. 
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3.5.4 Viscous media penetration test: IVF patients and donors 
Cells from 17 IVF patients and 18 donors were subjected to the viscous media 
penetration test, under control, vehicle and progesterone-treated conditions. Cells 
from 15 of the 17 IVF patients (88%) were able to significantly respond to 
progesterone in terms of increased cell number at 1cm in the viscous media penetration 
test, with only 2 patients (12%) had no significant response to progesterone. For the 
donors, cells from 15 of the 18 donors (83%) were significantly able to respond to 
progesterone at 1cm, and 3 (17%) were not able to respond to progesterone at all. 
Mean changes in cell density for IVF patients and donors under control, vehicle and 
3.6µM progesterone treatment are displayed in Figure 3.5. 
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Figure 3.5 Viscous media penetration test in IVF patients and donors. 
Progesterone treatment yielded an increase in cell count. Bars show average 
normalised cell count at 1cm within the viscous media. Donor n=18, IVF n=17. 
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3.5.5 Motility characteristics of sperm within synthetic cervical mucus 
Detailed motility characteristics for those sperm able to penetrate viscous media after 
control, vehicle control or progesterone treatment were compared between treatment 
groups for both IVF patients (n=17, Figure 3.6) and donors (n=18). This was 
performed using CASA by directly observing sperm swimming within the viscous 
media, following incubation of the samples for one hour. There was no significant 
difference in the distribution of any of the motility parameters examined within the 
viscous media, for either donors or IVF patients, under control, vehicle or 
progesterone-treated conditions, therefore the data is solely presented for IVF patients 
as described in Figure 3.6.  
Figure 3.6 (overleaf). Motility of sperm within viscous media. Motility kinetics 
analysis by CASA revealed that there was no significant differences in any motility 
parameters for the sperm observed within the viscous media penetration test, when 
treated with vehicle or progesterone and compared with control. There were no 
significant differences between motility of IVF or donor sperm sample motility 
(graph shows motility kinetics for IVF patients), n=17 for IVF patients. 
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3.5.6 Screening results: correlation with fertilisation rate in IVF 
All motility parameters under each treatment group during hyperactivation screening, 
cell count, degree of cellular penetration into methylcellulose, kinetics of sperm 
swimming within the methylcellulose, and calcium response to progesterone 
parameters were correlated with fertilisation success at IVF. None of these parameters 
were significantly positively or negatively correlated with fertilisation success, 
according to the Spearmans’s rank correlation coefficient (P>0.05). Examples of two 
of these correlations are given in Figure 3.7 below.  
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Figure 3.7 Correlating fertilisation rate with observed parameters. When 
comparing fertilisation rate of MII oocytes with peak calcium response and 
hyperactivation under control conditions, there was no significant correlation 
between the parameters, according to Spearman’s rank.  
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3.6 Discussion 
The primary aims of this chapter were to investigate the roles of 4-AP, progesterone 
and TMA on hyperactivation, the calcium response to progesterone and the viscous 
media penetration test on donor and IVF patient samples. Control data was obtained 
from donors to establish “normal” responses to hyperactivation screening, calcium 
response to progesterone and the viscous media penetration test. Patients were 
screened continuously throughout the project, in order to identify patients currently 
undergoing a treatment cycle that had a defective response to our analyses. Patient 
fertilisation success was also correlated with outcomes from the screening process.  
Up to 50% of the patients attending the Assisted Conception Unit are classified as 
having male factor infertility as defined by WHO criteria (Cooper et al., 2010). It was 
expected that IVF patient samples would have poorer motility parameters in the 
prepared capacitated sample than donor samples, due to their subfertile status. This 
was observed in the present study, where prepared sperm from donors had 
significantly greater sperm concentrations, sperm total motility, rapid motility and 
hyperactivated motility when compared with their IVF patient counterparts. This 
finding has corroborated the data presented in previously published papers (Alasmari 
et al., 2013a), that IVF patient motility is significantly lower than that of donors. 
After treatment with 2mM 4-AP, sperm hyperactivation was significantly increased 
compared to control levels of hyperactivated motility for both donors and IVF patients, 
as previously described (Gu et al., 2004). However the mean proportion of 
hyperactivated cells was reduced following 4-AP treatment in IVF patients when 
compared with progesterone, again verifying results identified previously (Alasmari 
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et al., 2013a). A lower proportion of sperm samples from IVF patients (66%) were 
able to significantly respond to 4-AP, compared with sperm samples from donors 
(80%).  As the samples were prepared in a similar manner and allowed to capacitate 
for the same length of time before being subjected to analysis, the difference in 
hyperactivation between donors and IVF patients could be indicative of the subfertile 
status of the patients (Munire et al., 2004).  
Neither progesterone (contrary to data published by Alasmari et al., 2013a) nor TMA 
were able to significantly stimulate an increase in hyperactivation in either donors or 
IVF patients. No motility parameters in either of the treatment groups were 
significantly different from control or the vehicle control. It is interesting to observe 
that although treatment with progesterone increases sperm ability to enter and progress 
through cervical mucus, there is no apparent change in motility detectable by CASA. 
Furthermore, although the time of analysis after progesterone treatment was chosen to 
coincide with the rapid transient increase of intracellular calcium as observed by 
fluorimetric methods, there was no corresponding increase in hyperactivation.  
The transient peak sperm calcium response, delta response, or basal calcium ratio were 
not significantly different between the donor and IVF patient population. Furthermore, 
raw calcium levels were not significantly different for both the 340 and 380 bound and 
unbound fluorescence intensities in IVF patient samples when compared with donor 
samples. The parameters that were found to be significantly different between the 
groups were an increased time to peak calcium response to progesterone, an increased 
duration of calcium response and an increased plateau phase calcium response in IVF 
patient samples. This was contrary to findings published in previous studies, where 
peak calcium response to progesterone was significantly reduced within IVF patient 
sperm samples (Falsetti et al., 1993, Alasmari et al., 2013a). In the present study, the 
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majority of possible confounding factors were controlled for: for example 
concentration of spermatozoa studied, dye concentration, incubation time and 
progesterone concentration. The one factor that was difficult to control for was IVF 
patient participation: only IVF patients with >4 million spermatozoa in the prepared 
sample received by the research laboratory from the ACU could be used in this 
experiment. This meant that a proportion of IVF patients with sperm number of <4 
million were not studied, thus excluding IVF patients with oligozoospermia. No ICSI 
samples were able to be investigated by this method, due to the restriction of cell 
numbers, therefore development of a more sensitive method of detection of calcium 
response to progesterone would clearly be beneficial in this case. 
Throughout the duration of the study, there was one incidence of an IVF patient 
sample which exhibited a complete absence of calcium response to progesterone when 
investigated with this technique. Such an outcome had not previously been identified, 
and this case is discussed in more detail in Chapter 4. 
The present study showed that similar proportions of IVF patients and donors, 15/18 
donors (83%) and 15/17 IVF patients (88%) showed greater numbers of sperm at 1cm 
after progesterone treatment, compared with control and vehicle control. However 
there was no significant change in motility parameters after treatment with 
progesterone to suggest the reason why this was possible, and furthermore there was 
no significant variation in motility parameters between IVF patient and donor sperm 
samples measured within the viscous media.  
Results from the motility analysis, calcium response to progesterone and viscous 
media penetration test were correlated with the fertilisation rate of all MII oocytes 
collected. There was no significant correlation, either positive or negative, between 
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any of the parameters studied and the fertilisation rate. This is in contrast to previous 
studies where parameters such as progesterone induced calcium responses and 
hyperactivation in response to 4-AP were found to be significantly correlated to IVF 
fertilisation rates (Alasmari et al., 2013a). This finding could be explained by the fact 
that only samples of >4 million cells could be examined for calcium response to 
progesterone, thus skewing the population of IVF patient samples studied. The one 
incidence of completely failed calcium response to progesterone did also experience 
total failed fertilisation, which may indicate that any calcium response above cut-off 
value does not affect fertilisation ability. 
Limitations of the current study include the difficulty in obtaining IVF patient samples 
of sufficient quality in order to carry out the screening tests. Many of the patient 
samples received were of insufficient sperm numbers for techniques that required a 
certain number of cells (such as 4 million cells required for the calcium response to 
progesterone assay). Furthermore, poor sperm concentration hampered the ability to 
perform multiple screening techniques on the same sample, and as such the calcium 
response to progesterone took precedence over hyperactivation assay and viscous 
media penetration test.   
Future experiments may include further development and sensitization of the 
screening techniques described in this chapter, to aid in the examination of 
spermatozoa from patients and donors with lower sperm counts or poorer recovery 
after density gradient centrifugation.  
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3.7 Conclusion 
Although there was no significant correlations between any of the parameters 
investigated in this study with fertilisation rates at IVF, cells from IVF patients had a 
significantly lower level of basal hyperactivation, and defects were present in an 
individual patient when investigating the calcium response to progesterone. Samples 
from IVF patients and donors performed similarly in the viscous media penetration 
test.  
The study identified one male with significant abnormalities, which will be discussed 
in more detail in Chapter 4. 
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Chapter 4 
Analysis of calcium response to progesterone in patients 
recalled due to previous failed/low fertilisation treatment 
outcomes 
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4.1 Introduction 
The live birth rate per cycle of IVF or ICSI started remains relatively low at 32.8% for 
women under 35 (HFEA, 2014). Adverse treatment outcomes affecting all stages of 
assisted reproduction contribute to the low birth rate (Huang and Rosenwaks, 2012). 
This chapter will focus on one of the arguably most significant stages of ART and IVF 
in particular: fertilisation of the oocyte. The incidence of total fertilisation failure 
(TFF) remains around 5-10% in all IVF cycles and 1-3% of all ICSI cycles (Barlow et 
al., 1990, Ruiz et al., 1997, Bhattacharya et al., 2001, Repping et al., 2002), with 
recurrence rate of a further TFF outcome in a subsequent treatment cycle estimated to 
be 30-65% (Roest et al., 1998).  
Failed fertilisation in IVF or ICSI may be attributed to a number of causes (Barlow et 
al., 1990, Liu and Baker, 2000, Mahutte and Arici, 2003), yet in the clinical ART 
laboratory setting, it is generally not known whether failed fertilisation can be directly 
linked to either the male or female partner. As male causes cannot be detected by basic 
semen analysis, research tools such as the hemizona binding assay have previously 
been used to diagnose male factor infertility. However, they are currently rarely used 
despite their apparent value, partly due to the employment of ICSI technique for cases 
of male factor infertility (Oehninger et al., 2014). The present study used the screening 
research techniques described in Chapter 3 as a novel approach in investigating sperm 
function in semen samples from males who had an IVF, or ICSI treatment cycle where 
sperm numbers were suitable for analysis, where the outcome was failed or low 
fertilisation. These patients were recalled for a consultation, and were requested to 
provide a further semen sample for research. This research could provide valuable 
information regarding the direction of the next treatment cycle for the patient. 
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4.2 Aim 
The aims of this chapter were to investigate semen samples from patients that had 
suffered a previous low or TFF in IVF or ICSI, and to use different research techniques 
to identify defects in sperm function leading to male factor infertility.  
 
4.3 Hypothesis 
Incidence of sperm dysfunction and specifically calcium pathway defects will be 
significantly higher in patients who have experienced at least one cycle of TFF, than 
IVF patients and donors. 
 
4.4 Methods 
Sixteen IVF patients and two ICSI patients were asked to attend a follow-up 
appointment with Dr Sarah Martins da Silva following failed or low fertilisation in a 
previous treatment cycle, and provided at least one semen sample for research. Semen 
samples were produced and prepared as previously described. Calcium response to 
progesterone, basal and stimulated hyperactivation and the viscous media penetration 
test were all performed as previously described. Electrophysiological techniques 
performed by Dr Sean Brown to investigate both Ca2+ and K+ channel conductance, 
was applied to capacitated spermatozoa from eight of the patients as previously 
described.   
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4.5 Results 
Clinical features of the recalled patients are presented in Table 4.1. Of the 18 patients, 
the majority (12/18, 67%) were described as having unexplained infertility, with 4 
suffering from PCOS (polycystic ovarian syndrome, 22%). One patient had male 
factor infertility due to a vasectomy reversal, and one had a recorded cause of 
infertility due to being an offshore worker (infertility due to the male partner’s job 
obstructing coitus in fertile period). Average duration of infertility was 2.9 years ±1.3 
SD. Mean male age was 36 years ± 5.6 SD, while mean female age was 34 years ± 5.1 
SD. 
Patient code Recorded cause IVF/ICSI Duration Male age Female age 
Patient A Unexplained IVF 2 43 39 
Patient B Unexplained IVF 5 24 25 
Patient C Male factor ICSI 3 40 36 
Patient D Offshore worker IVF - - - 
Patient E Unexplained IVF 2.5 42 38 
Patient F Unexplained IVF 2 34 30 
Patient G Unexplained IVF 2.25 37 36 
Patient H Unexplained IVF 2 36 36 
Patient I Unexplained IVF - 33 28 
Patient J Unexplained IVF 5 36 39 
Patient K PCOS IVF - 36 36 
Patient L PCOS ICSI 5 44 31 
Patient M Unexplained IVF 1.5 31 33 
Patient N PCOS IVF 3 27 25 
Patient O Unexplained IVF 1.5 34 34 
Patient P Unexplained IVF 2 33 37 
Patient Q Unexplained IVF 3 40 44 
Patient R PCOS IVF 4 42 36 
 
 
 
Table 4.1 Clinical features of recalled patients. Recorded cause of infertility, 
treatment, duration of infertility, male and female age. “-“ denotes that details are not 
known for this parameter. 
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4.5.1 Calcium response to progesterone 
Each of the 18 sperm samples were analysed for their calcium response to 
progesterone by FLUOstar Omega microplate method. All samples except one, which 
will be discussed in more detail in section 4.5.6, were able to significantly respond to 
progesterone (17/18, 94%). When comparing recall patients with IVF patients and 
research donors, there was no significant differences in the peak, delta or plateau 
calcium response to progesterone (Figure 4.1, one-way ANOVA, P=0.0525, 
P=0.0546 and P=0.0635 respectively), or in the duration of the response (Figure 4.1, 
one-way ANOVA, P=0.0850). However, the time taken to achieve peak response was 
significantly different among the three groups (Figure 4.1, one-way ANOVA, 
P=0.0028).  
Tukey’s multiple comparison test revealed a significant increase in time to peak for 
recall patients when compared with donors, and the same phenomenon between IVF 
patients and donors (as previously described in section 3.3), but there was no 
significant difference between recall and IVF patients. 
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Figure 4.1 Calcium response to progesterone in donors, IVF and recalled patients. 
There was no significant difference in B) plateau phase, C) peak or D) delta calcium 
response to progesterone or F) duration of peak between Recall patients, IVF patients or 
donor samples. However E) time to peak was significantly increased for IVF patients and 
Recall patients when compared with donor samples. Error bars on A) indicate SEM. Arrow 
indicates time of progesterone addition. 
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4.5.2 Viscous media penetration test 
Five of the 18 recall patients had sufficient sample in order to study their response in 
the viscous media penetration test (Figure 4.2). Numbers of sperm that were able to 
reach 1cm in the synthetic cervical mucus-filled capillary tubes were compared 
between control, vehicle and 3.6µM progesterone-treated groups (Figure 4.2). Of the 
5 patients, 3 (60%) were able to significantly respond to progesterone, whereas 2 
(40%) were unable to respond significantly to progesterone.  
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4.5.3 Hyperactivation in response to 4-AP, TMA and progesterone 
Seven of the 18 patients had sufficient sample to investigate their hyperactivation 
response to stimuli: 4-AP, progesterone and TMA. Overall, there was no significant 
difference between any motility parameter studied between treatment groups 
(representative graphs displaying hyperactivation, VAP, ALH and LIN motility 
Figure 4.2 Viscous media penetration of recall patient samples. The mean cell 
ratio at 1cm was significantly increased on addition of progesterone (n=5). Error 
bars indicate SEM. 
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parameters are shown in Figure 4.3 below). Only two of these seven patients (29%) 
were able to significantly positively respond to 4-AP (One-way ANOVA with Tukey’s 
multiple comparison test), a significantly lower proportion than for donor or IVF 
patient sperm samples.  
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Figure 4.3 Motility parameters for recall patients. There was no significant 
difference in hyperactivation, VAP, ALH or LIN motility parameters between 
control, 4-AP, progesterone and TMA treatment groups for Recall patients (n=7). 
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4.5.4 Whole-cell patch clamp electrophysiology 
Whole-cell patch clamp was performed on seven of the 18 patients. Two of these 
patient samples who produced abnormal responses to this assay will be discussed in 
further detail in sections 4.5.5 and 4.5.7. The remaining five samples were able to elicit 
a significant outward K+ current upon application of ramp stimulus under quasi-
physiological conditions (Figure 4.4).  
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Figure 4.4 Electrophysiological recording of sperm from recall patients. Sperm 
cells of Patients G, I, K, L and M were able to elicit significant outward currents in 
response to ramp stimulus, similar to donor control cells. Patient cell n = 1, apart 
from Patient M (n = 3 cells). Donor cell number was 47. Error bars on the donor 
trace represent SEM. 
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4.5.5 Patient A 
Patient A attended the “Failed fertilisation clinic” after a total failed fertilisation 
outcome in an IVF treatment cycle. Patient A and his partner were allocated to IVF 
treatment as semen parameters were normal, according to WHO 2010 semen analysis, 
and their infertility (duration of >2 years) was unexplained. Patient A had good initial 
semen parameters on the first day of experimentation: the concentration of sperm in 
seminal plasma was 121M/ml, semen volume was 4ml, 76% motile and 49% 
progressively motile. The prepared sample of spermatozoa had a concentration of 
74.8M/ml, total motility of 97% and progressive motility of 76%. 
The viscous media penetration test, calcium response to progesterone and analysis of 
hyperactivation both basally and in response to 4-AP and progesterone were studied. 
The calcium response to progesterone was studied on two separate ejaculates more 
than 8 weeks apart. Although the second semen sample exhibited a concentration of 
11.8M/ml, lower than the 95th centile of WHO 2010 criteria (15M/ml), total motility 
and progressive motility were normal (43% and 38% respectively). The result 
observed was consistent between these two separate ejaculates. 
The sperm cells of Patient A were unable to respond to progesterone in the population 
calcium assay or in the viscous media penetration test (Figure 4.5, B and C). Patient 
A was the only recall patient of 17 studied to present with this phenomenon. The repeat 
sample 8 weeks later, run parallel to a donor control sample, confirmed the previous 
findings (Figure 4.5, D). The cells of Patient A were subjected to calcium ionophore 
A23187 treatment following pre-incubation with Fura-2/AM, which elicited a 
sustained rise in intracellular calcium, indicating dye loading had taken place (data not 
shown).  
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The sperm cells of Patient A showed normal basal levels of hyperactivation on motility 
analysis, with a significant positive response upon addition of 2mM 4-AP (Figure 4.5 
A). 
Results from electrophysiological analysis of the sperm under Cs+ based divalent free 
conditions and depolarizing ramp protocol revealed that CatSper current (ICatSper) was 
absent when compared with normozoospermic donors (maximum outward current 4.0 
± 0.4 pA/pF versus 204.6 ± 17.7 pA/pF respectively, P<0.01), as shown in Figure 4.6. 
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Figure 4.5 Patient A. Sperm cells from Patient A were able to A) significantly respond 
to 4-AP by increasing hyperactivation, however were unable to respond to progesterone 
in the B) viscous media penetration test or C) initial or D) second fluorimetric assay. 
Arrow indicates progesterone addition. 
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Patient A was recalled to the Sperm Studies Clinic due to experiencing total failed 
fertilisation of all 9 oocytes inseminated via IVF. Following these findings and the 
normal recommendations following a failed fertilisation in IVF, Patient A and his 
partner returned for a further cycle where ICSI was employed. This resulted in 5 out 
of 6 eggs injected displaying normal fertilisation (2PN, 2PB). However, embryo 
development failed to progress past day 3, therefore embryo transfer was not 
performed. 
Patient A Cs+ Ramp
-100 -50 50 100
-100
100
200
300
Donors
Patient A
                                   Vm (mV)
C
u
rr
e
n
t 
(p
A
/p
F
)
 
 
 
 
 
 
 
Figure 4.6 Electrophysiological analysis of sperm from Patient A. Sperm cells 
from Patient A showed no discernible CatSper current, in comparison with donor 
sperm cells under Cs+-based divalent-free conditions (n=7). Error bars represent 
SEM. 
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4.5.6 Patient B 
Patient B produced his sample on the day of IVF treatment; and surplus sample was 
donated to research following oocyte insemination. The concentration of the prepared 
sample was 17.6M/ml, volume was 0.7ml, 82% total motility, 50% progressive 
motility, 29% hyperactivated motility. The viscous media penetration test, calcium 
response to progesterone and hyperactivation to 4-AP were performed. It was 
observed that the sperm cells of Patient B was unable to respond to progesterone both 
in the fluorimetric technique (Figure 4.4E, no peak observed) and in the viscous media 
penetration test (Figure 4.4C, one way ANOVA with Tukey’s multiple comparisons); 
however 4-AP was still able to induce an increase in hyperactivation over basal levels 
(Figure 4.4A, Student’s paired t-test, P=0.0106). This was in accordance with the 
results previously observed for Patient A. Furthermore, again it was noted that in this 
IVF all 9 oocytes had failed to fertilize (no PN structure, <2PB).  
However when Patient B was recalled to provide a further sample for research 7 
months later, it appeared that CatSper function had been restored as the sample was 
able to significantly respond to progesterone when assayed in both the viscous media 
penetration test and calcium response to progesterone (Figure 4.4 D, F respectively). 
Conversely in this sample, sperm cells were unable to significantly respond to 2mM 
4-AP (Figure 4.4B). This sample was used in ICSI treatment, where 2 of the 5 MII 
oocytes inseminated resulted in normal fertilisation (40%), however embryo transfer 
did not result in a pregnancy. 
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Figure 4.7 Patient B. Analysis was performed on two occasions. Cells from the 
initial sample were tested for hyperactivation (A), viscous media penetration (C) 
and calcium response to progesterone compared to the control donor sample run 
concurrently represented by the grey trace (E). Cells from the second sample were 
again tested for hyperactivation (B), viscous media penetration (D) and calcium 
response to progesterone (F). Arrow indicates progesterone addition. 
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4.5.7 Patient C 
Patient C attended the ACU with his partner for a treatment cycle, and consented for 
his surplus sample to be donated to research. Patient C and his partner had a duration 
of infertility of 3 years, with the cause given as male infertility, although his vasectomy 
reversal was successful, as indicated by the presence of motile sperm in his ejaculate. 
The volume of prepared sperm received was 0.3ml, with a concentration of 22.3M/ml, 
total motility 75% and progressive motility 53%. Although this patient exhibited a 
normal count and motility of sperm, his vasovasostomy had led to the production of 
anti-sperm antibodies, thus resulting in agglutination and aggregation of the sperm. 
Therefore this patient was allocated to ICSI treatment.  
The calcium response to progesterone was originally carried out on Patient C’s non-
capacitated sample, leading to a reduced peak response (Figure 4.7A). Hyperactivation 
in this patient was normal, with a significant response to 2mM 4-AP (Figure 4.7C). 
Furthermore, following fertilisation check, it was found that a total failed fertilisation 
of all inseminated oocytes had occurred. This was unexpected as his semen parameters 
were largely normal; additionally this patient had two children from a previous 
relationship.  
The patient produced a further sample for research. Prepared sperm parameters were 
normal: concentration was 50.3M/ml, motility 93% and progressive motility 62%. The 
sample was capacitated, and the calcium response to progesterone was found to be 
normal (Figure 4.7B). However upon applying the whole-cell patch clamp technique 
to the sperm, absence of the potassium current was discovered (Figure 4.7D).  
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Figure 4.8 Patient C. The sperm cells of Patient C was significantly able to 
respond to progesterone when both A) non-capacitated, although this response was 
low, and B) capacitated. Cells of Patient C were furthermore able to C) 
significantly respond to 2mM 4-AP. However, electrophysiological analysis 
revealed the absence of a significant potassium current (D). 
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4.6 Discussion 
Failed fertilisation is a significant negative outcome of IVF and ICSI cycles, often 
unpredictable by conventional basic semen analysis and occurs without obvious cause 
or explanation (Mahutte and Arici, 2003). This is stressful, difficult and frustrating for 
both the patient and the embryologist performing the ART procedure. Currently, 
semen analysis for the assessment of male fertility is limited by the inadequacy of 
counting sperm and assessing their motility to try and predict sperm function (Wang 
and Swerdloff, 2014), yet this represents the current clinical standard. Previous 
research techniques used in the clinical setting to assess male infertility, such as the 
hemizona assay, have fallen out of favor in recent years and are no longer routinely 
carried out (Oehninger et al., 2014). Therefore this study took a novel approach and, 
for the first time, aimed to use published research techniques (Alasmari et al., 2013a, 
Alasmari et al., 2013b) to analyse sperm from male patients who had already 
experienced failed/low fertilisation in IVF or ICSI for the presence of calcium pathway 
defects.  
Patient A and Patient B both failed to elicit a peak in intracellular calcium following 
treatment with progesterone. Furthermore both patients also failed to significantly 
enhance penetration into the viscous media penetration test when stimulated with 
progesterone. Interestingly for Patient A, CatSper dysfunction persisted over the 8 
weeks between analyses, however the same was not the case for Patient B where 
CatSper function was restored on second analysis 7 months later and following 
antioxidant treatment. The initial failure to respond to progesterone in these 
experiments suggests the aberrant expression or complete absence of the human sperm 
cation channel, CatSper, which has been shown to be activated by progesterone. 
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Several men with an infertility phenotype have also previously been found to have 
deletions or aberrant expression of the CatSper gene (Avidan et al., 2003, Nikpoor et 
al., 2004, Qi et al., 2007, Avenarius et al., 2009, Hildebrand et al., 2010, Smith et al., 
2013). Considering that sperm from males who were previously found to have CatSper 
defects were also severely astheno-teratozoospermic (Smith et al., 2013), it was 
unclear whether poor motility/morphology or homozygous deletion of CatSper2 was 
the principal cause of infertility in that case. In the present study, both Patients A and 
B had normal semen parameters according to WHO (2010). Furthermore, sperm from 
both men were able to significantly respond to the putative calcium store releasing 
agent 4-AP as described previously (Alasmari et al., 2013a), indicating that their 
inability to fertilize oocytes was not due to a calcium store defect.  
The hypothesis that CatSper dysfunction was to blame for the failed fertilisation in 
Patient A’s IVF treatment cycle was further confirmed by the successful fertilisation 
of 5/6 oocytes after ICSI treatment: where there is no functional requirement for the 
human sperm to penetrate the oocyte and therefore no requirement for functional 
CatSper. One interesting finding in this study was that both patients unable to respond 
to progesterone were still able to robustly hyperactivate, contrary to previous findings 
in mice (Ren et al., 2001, Quill et al., 2003). However, mice do not exhibit the same 
CatSper progesterone responsiveness as humans, therefore species differences will 
reveal separate phenotypes of the sperm deficient in the functional CatSper channel. 
K+ channels function to maintain the membrane potential (Vm) in human spermatozoa 
at negative values (hyperpolarized). Slo3 has been found to be the primary K+ channel 
in mice, together with the auxiliary subunit LRRC52 (Navarro et al., 2007, Zeng et 
al., 2015). Spermatozoa from animals lacking either of these channels show 
significantly depolarized membrane potential, which was shown to have a significant 
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negative effect on motility and ability to hyperactivate, and furthermore resulted in a 
reduction in fertility (Santi et al., 2010). However previously, little was known of the 
role of K+ channels on human sperm function. The activity of K+ channels was 
investigated in the current study by whole-cell patch clamp technique. In a novel 
finding, spermatozoa examined from one ICSI patient were found to have a severely 
defective K+ current, suggesting absence of the KSper potassium channel. This finding 
elaborates on the knowledge of functional importance of KSper on human sperm 
function, however could also be indicative of more severe sperm dysfunction as the 
failed fertilisation in this case was encountered in an ICSI cycle, where the functional 
requirements of sperm were abolished. 
There were several patients who did not show an abnormal response in any of the 
experiments performed. As male factor infertility is thought to account for up to 50% 
of problems in conceiving in infertile couples (Health, 2009), it is plausible that the 
failed fertilisation observed was of a female-derived or oocyte origin. Otherwise, the 
failed fertilisation could have been the result of a sperm factor as yet unidentified by 
the limitations of our experimental techniques.  
The main limitation of this study was the select number of research techniques able to 
be employed, coupled with the limited concentration of sperm obtained from the 
recalled patient samples. This often gave an incomplete view of where the cause of 
failed fertilisation lay, which required the patient to, if willing, submit a further sample 
for research. Furthermore, if a patient had failed fertilisation after IVF, ICSI would be 
recommended in the next cycle, which limited the predictive value of our research. 
The study would have also benefited from receiving several samples from each 
patient, to exclude the possibility of inter-ejaculate variability. 
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4.7 Conclusion 
In conclusion, the present study describes the novel finding of two normozoospermic 
males exhibiting defective CatSper function, thus leading to failed fertilisation in their 
IVF treatment cycles. Furthermore, this study presents the first description of a male 
ICSI patient with severe K+ channel dysfunction. 
There are many varied reasons behind total failed fertilisation that are not normally 
recognized in a typical treatment cycle. The belief is that around half of these 
outcomes originate from the male (sperm), and half from the female partner (oocyte). 
By examining the sperm of males who have previously endured total failed 
fertilisation in a treatment cycle, we have identified several causes of male origin 
including CatSper defects and potassium channel deficiency. There were however, 
many others with no obvious defects identifiable with the research techniques 
employed. Further studies must work on identifying these causes, to develop novel 
screening techniques to detect sperm dysfunction or male infertility prior to treatment. 
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Chapter 5 
Development of imaging groups of individual cells in response 
to progesterone in donors, IVF and ICSI patients 
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5.1 Introduction 
Previous studies examining the intracellular calcium response to progesterone in IVF 
and ICSI patients investigated a largely heterogeneous population of spermatozoa 
(Alasmari et al., 2013a, Alasmari et al., 2013b). While population-based fluorescent 
imaging techniques are valuable for observing ionic kinetics occurring over time, they 
provide an average cellular fluorescence intensity which is ultimately unable to 
resolve whether each individual cell is responsive, or to what extent. Furthermore, 
population assays tend to require large numbers of sperm in order to produce 
repeatable and reliable results (as described in Chapter 3), which can lead to samples 
of lower sperm concentrations (<4M/ml for IVF, and the vast majority of ICSI 
samples) being unsuitable for analysis and thus remain unstudied. Therefore there is a 
clear need to utilise a more sensitive technique with improved resolution, in order to 
further distinguish calcium responses to progesterone between spermatozoa of patients 
and donors, particularly those patients with poor sperm concentrations. 
Calcium imaging of groups of individual cells in response to progesterone in human 
spermatozoa has previously been extensively described for donor samples (Kirkman-
Brown et al., 2000, Harper et al., 2003, Kirkman-Brown et al., 2003, Kirkman-Brown 
et al., 2004, Bedu-Addo et al., 2007, Nash et al., 2010, Alasmari et al., 2013b, Mata-
Martinez et al., 2013). The technique has been developed over the past 20 years to 
monitor changes in free intracellular calcium ion concentrations (Tesarik et al., 1996), 
and has observed phenomena such as calcium oscillations in individual sperm cells in 
response to stimuli such as progesterone: this would not have been possible in whole-
population assays. However, the single-cell response to progesterone in spermatozoa 
from patients attending for assisted conception has not been previously described. 
96 
 
5.2 Aims 
This study aims to describe the development of methods for use of single-cell calcium 
imaging. Furthermore, the study aims to investigate variation in calcium response to 
progesterone in individual cells from donor sperm samples, IVF sperm samples and 
ICSI sperm samples.  
 
5.3 Hypothesis 
The hypothesis states that the calcium response to progesterone within individual 
spermatozoa will reveal significant variation in proportion of responsive cells, and 
amplitude of response, between donors, IVF and ICSI patients.  
 
5.4 Development of the materials and method 
5.4.1 Materials 
The single wavelength dye Fluo-4/AM (Molecular Probes, Thermo Fischer Scientific, 
MA, USA) 494nm excitation, 506nm emission, was used as the fluorescent calcium 
indicator. Uneven dye loading between cells was corrected by normalising the trace 
to 1 using the equation given in Chapter 2. Fluo-4 with AM ester was chosen over the 
salt form, as the hydrophobic dye was passively membrane-permeable, and was able 
to concentrate within the intracellular cytoplasm (Paredes et al., 2008). Fluo-4/AM 
can be used at a final concentration of 1-10µM (Invitrogen, 2010), and the 
concentration of fluorescent calcium indicator used was 1µM (Shahar et al., 2011).  
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Poly-D-lysine: varying concentrations of poly-D-lysine were investigated (1% w/v, 
0.1% w/v, 0.01 w/v and 0.001% w/v). The aim was to obtain sperm heads loosely 
adhered to the glass coverslip, with tails minimally motile. It was found that the 
concentration that had the best compromise between maximum sperm “sticking” and 
minimal free-swimming sperm was 0.1% poly-D-lysine, so was used for all future 
experiments. 
Progesterone was administered after 100 intervals (44 seconds) of basal calcium 
fluorescence recording. Progesterone was solubilised in 100% ethanol at 36mM 
concentration before it was diluted in either Quinns HTF media lacking protein, or 
STF as used in FLUOstar Omega, to a final concentration of 36µM. When added in a 
1:10 ratio, this gave a final concentration of 3.6µM progesterone. As STF gave a large 
“mixing artefact” due to the difference in media being added (STF did not contain 
Phenol red), Quinns HTF was used for the duration of the study. The final 
concentration of progesterone was maintained at 3.6µM, equivalent to the 
concentration used in the FLUOstar Omega. 
Ca2+ ionophore A23187: Addition of ionophore A23187 was incorporated in the 
experimental design in order to calibrate the fluorescence to calculate calcium 
concentration (Bootman et al., 2013). Addition was performed 150 intervals (66 
seconds) after progesterone addition. However, response to ionophore varied 
drastically within a sample, and between samples from different individuals. 
Therefore it was difficult to establish a protocol for accepting or rejecting individual 
cellular responses to ionophore. Use of ionophore for max-min calculations, was not 
performed however is still included on the graphs for information purposes. 
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5.4.2 Method 
Open system: use of an open imaging system was used, to avoid tubing contamination 
by agonist in perfusion systems, and to replicate the conditions of the FLUOstar 
fluorescence microplate reader described in Chapter 3. Thus, sperm were centrifuged 
after dye incubation, before being resuspended in 45µl protein-free HTF media. 45µl 
of the sperm solution was added to the glass coverslip for imaging. Addition of 5µl of 
36µM progesterone was performed to a final concentration of 3.6µM progesterone, 
mimicking the volumes of solution used in the FLUOstar system.  
Semen preparation: previous studies have utilised swim-up harvesting procedure 
(Kirkman-Brown et al., 2000, Kirkman-Brown et al., 2004), whereas other used 
density gradient (Tesarik et al., 1996). In the present study, due to all clinical samples 
being prepared for IVF and ICSI by density gradient centrifugation, this was also used 
in the research lab to prepare donor samples to ensure continuity and comparability. 
Temperature: due to the use of an open coverslip system sensitive to evaporation and 
previous studies using 25°C as the set temperature, 25°C was used as the set 
temperature in the present study (Plant et al., 1995, Kirkman-Brown et al., 2000, 
Kirkman-Brown et al., 2004). 
Regions of interest (ROI) were produced automatically by the computer software 
MetaFluor. These shapes covered the entire sperm head. It was important for the ROIs 
to always be checked manually for fidelity as some ROIs were placed erroneously by 
the software, and were removed and re-drawn manually if they did not meet the 
expected standard. 
99 
 
Experimental timings: timing of drug/stimuli addition was a compromise between 
avoiding media evaporation and resultant increase in osmolality, and recording all 
kinetic events after progesterone addition (transient and plateau phase calcium 
response) and ionophore/EGTA addition within a suitable timeframe. Total recording 
time was 3 mins 40 seconds, with 500 recordings being taken 440ms apart. Basal 
recordings of fluorescence intensity were performed for 100 intervals (44 seconds). 
Progesterone addition was performed, and recording proceeded for 150 intervals (66 
seconds), which was deemed an acceptable length of time according to Chapter 3 
where peak transient calcium response to progesterone occurred within one minute of 
addition. Ionophore addition was performed, and recording proceeded for 100 
intervals (44 seconds). EGTA was added and recording proceeded for a further 150 
intervals (66 seconds).  
Dye loss: occasionally, sperm were seen to show a decrease in fluorescence intensity 
over time. This was previously observed, and reported as dead or dying cells being 
unable to maintain dye loading and thus dye leakage occurred (Tesarik et al., 1996, 
Kirkman-Brown et al., 2000). Any cells visualised to be doing this, either during data 
acquisition or after data processing were excluded from analysis.  
Negative control: 0.01% final concentration of ethanol in HTF was used as negative 
control in samples from three donors. Ethanol was unable to stimulate any significant 
calcium responses after addition. Examples of the single cell traces obtained from one 
of these donors is shown below (Figure 5.1).  
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Figure 5.1 Single cell calcium response to vehicle. Treatment with vehicle 
(indicated by first arrow on top panel) did not cause a significant change in 
intracellular calcium. The arrows indicated vehicle/progesterone, ionophore 
A23187, and EGTA addition respectively. 
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5.5 Results 
5.5.1 Capacitation of the samples 
While IVF samples from the Assisted Conception Unit were received in capacitating 
medium for over 4 hours, ICSI samples were maintained in non-capacitating gamete 
buffer. Due to the experimental constraint of low sperm numbers in ICSI samples, care 
was taken to obtain as many sperm as possible for evaluation. Re-suspending the ICSI 
samples in capacitating medium risked losing sperm in the wash steps. Therefore 
capacitated and non-capacitated donor samples were compared for analysis of whether 
capacitation status affected the proportion of cells responding to progesterone and 
their average area under the curve. Capacitation status did not affect average area 
under the curve, and the proportion of sperm responding to progesterone was 
significantly higher when not capacitated in donor samples, therefore ICSI samples 
were maintained in non-capacitated medium with no detrimental experimental effect. 
As described in Figure 5.2, there was no significant difference in the average area 
under the curve between capacitated and non-capacitated donor samples (Mann 
Whitney test, P=0.14), however the proportion of cells able to positively respond to 
progesterone was significantly higher in non-capacitated samples (Student’s unpaired 
t-test, P=0.021). 
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5.5.2 Example traces from one donor, one IVF patient and one ICSI patient  
21 IVF patient sperm samples and 10 ICSI patient sperm samples were evaluated for 
their calcium response to progesterone. This was compared with 17 samples from 9 
donors. Representative example traces from one IVF patient, one ICSI patient and one 
donor sample are shown below (Figure 5.3). 
Figure 5.2. Capacitated versus non-capacitated single cell calcium response to 
progesterone. Comparison of mean area under the curve after 3.6µM progesterone 
addition and percentage of donor sperm cells responding to progesterone in 
capacitated (cap) and non-capacitated (non-cap) samples. There was no significant 
difference in area under the curve between the two treatment groups (P=0.14), 
however a significantly higher proportion of cells were able to respond to 
progesterone when maintained in non-capacitating conditions (P=0.021). 
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Figure 5.3 Example traces of individual cells from a donor, an IVF patient and 
an ICSI patient. Addition of progesterone, ionophore A23187 and EGTA are 
indicated by each of the arrows respectively. The total duration of each recording 
was 3 minutes 40 seconds. 
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5.5.3 Proportion of sperm responding to progesterone 
Comparisons were made between the proportion of sperm responding to progesterone 
for IVF and ICSI patients and normozoospermic donors. As described in Figure 3.2, 
single cell calcium imaging revealed there was no significant difference in the 
proportion of responsive sperm: an average of 53% for donors, 52% for IVF patients 
and 46% of ICSI patient sperm responding after addition of progesterone (Figure 5.4, 
one-way ANOVA, P=0.698).  
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Figure 5.4 Proportion of progesterone-responsive cells. There was no 
significant difference in the proportion or distribution of sperm cells positively 
responding to progesterone between donors, IVF and ICSI patients (P=0.698). 
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The 5th centile for the proportion of sperm from donor samples positively responding 
to progesterone was 20.9%. One IVF patient (1 of 21, 4.8%), one ICSI patient (1 of 
10, 10%) and one donor (1 of 17, 5.9%) had samples with proportions lower than 
20.9% responding to progesterone. 
  
5.5.4 Area under the curve analysis 
To quantitatively analyse the extent to which individual cells were able to produce a 
calcium response to progesterone, area under the curve analysis was performed. Cells 
where the area under the curve yielded a negative value were excluded from further 
analysis. Analysis showed that there was no significant difference in the average area 
under the curve between IVF patients, ICSI patients and donor samples (Figure 5.5, 
Kruskal Wallis test, P=0.7099).  
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The 5th centile for fluorescence intensity was 1698.6 relative fluorescence units. One 
ICSI sample (1 of 10, 10%) and one donor sample (1 of 17, 5.9%) exhibited average 
fluorescent intensity of less than 1698.6 relative fluorescence units. No samples from 
IVF patients were below the 5th centile. 
 
5.5.4.1 Area under the curve frequency distributions in individual patients 
The frequency distributions from the area under the curve for single cells responding 
positively to progesterone in individual IVF and ICSI patients are plotted in Figure 
5.6. The frequency distributions display that while the majority of single cells have a 
fluorescence intensity2 of between 0-6000RFU2 in both IVF and ICSI patients, a small 
proportion of cells display a significantly greater response (cells present in IVF 
samples 1 and 2, ICSI samples 1 and 3, up to 28,000RFU2).  
Figure 5.5 Area under the curve analysis. There was no significant difference in 
area under the curve between IVF patients, ICSI patients and donors (P=0.7099). 
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Figure 5.6.  Frequency distributions for the area under the curve of individual 
sperm cells. The distribution of fluorescence intensity2 values for different patients 
is variable. 
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5.5.5 Absence of the second phase 
Due to the relatively short period of time monitoring calcium response to progesterone 
(66 seconds) 3 of the patient samples were selected for extended analysis of the 
calcium response to progesterone. In this experiment, calcium ionophore A23187 and 
EGTA were not added.  
Over the 176 seconds of recording with progesterone present, there was no significant 
secondary phase response in any of the samples studied (Figure 5.7), contrary to 
findings reported in previous studies (Kirkman-Brown et al., 2000). Furthermore no 
significant evidence of calcium oscillations was observed contrary to previous reports 
(Harper et al., 2004, Kirkman-Brown et al., 2004). However the duration of recording 
in the present study was shorter than previously reported (3.5 minutes as opposed to 
>10 minutes). 
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Figure 5.7 Second phase of calcium response to progesterone. There was no 
obvious second phase to the calcium response to progesterone over the duration of 
recording. Arrow indicates time of progesterone addition. 
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5.5.6 Correlation with IVF and ICSI fertilisation rate 
There was no significant correlation between the average fluorescent intensity of 
responsive sperm nor the proportion of sperm that responded to progesterone and the 
fertilisation rate of solely MII oocytes or all collected oocytes after IVF treatment. 
This is in agreement with the results presented in the previous study (Chapter 3), where 
there was no significant correlation between any of the parameters observed for the 
population calcium response to progesterone assay (Figure 5.8).  
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Figure 5.8 Correlation between IVF fertilisation rate and single cell calcium 
imaging results. No significant correlation was observed between IVF patient 
single cell fluorescence intensity nor proportion of responsive cells to IVF 
fertilisation rate.  
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Interestingly, although there was no significant correlation between ICSI patient 
average fluorescent intensity and fertilisation rates or proportion of responsive sperm 
versus fertilisation of MII oocytes only, there was a significant positive correlation 
between the proportion of responsive sperm and total fertilisation rate (Figure 5.9, 
Pearson product-moment correlation coefficient r=0.7802, P=0.0131). 
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Figure 5.9 Correlation between ICSI fertilisation rate and single cell 
calcium imaging results. There was no significant correlation between average 
fluorescent intensity and fertilisation rate of ICSI samples, however there was 
significant positive correlation between the proportion of responsive cells and 
the total fertilisation rate (Pearson’s r = 0.7802, P= 0.00131, R2 = 0.6087).  
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5.6 Discussion 
The aims of the present study were to describe the development of methods for the 
single cell imaging system, and to use this system to investigate, for the first time, 
changes in single sperm calcium responses to progesterone from IVF and ICSI 
patients. In the present study, methods were described for the set-up of this single cell 
calcium imaging experiment, including experimental timings, conditions, reagents 
used, protocol devised and rationale behind these decisions.  
Previous population-based studies on sperm calcium response to progesterone did not 
show a significant difference between donors and IVF patients, however ICSI samples 
produced a significantly lower response to progesterone (Alasmari et al., 2013a). This 
was not the case in the present study, as ICSI samples produced comparable 
proportions of cells forming a positive calcium response to progesterone, with 
comparable average area under the curve. ICSI samples routinely contain lower 
concentrations of sperm, sperm with poor motility, poor morphology or a combination 
of two or more of these indications. However from the data discussed in the present 
study, this does not seem to have a detrimental effect on the ability of these cells to be 
able to respond to progesterone. A caveat to this conclusion is that only the ICSI 
samples received post-ICSI procedure with sufficiently concentrated and motile 
spermatozoa were suitable for study: ruling out those samples with severe 
oligozoospermia where <10 sperm were seen in a 4µl aliquot, or severe 
asthenozoospermia where motility was significantly impaired, or a combination of the 
two. Thus the ICSI samples studied were of a specific sub-group, where male 
infertility pathogenesis was less pronounced. It would be of interest to develop a more 
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sensitive method to study the most severely oligo/asthenozoospermic samples for their 
ability to respond to progesterone.  
The present study indicates that around 50% of both IVF/ICSI patient and donor sperm 
cells have the capacity to produce a significant calcium response to progesterone, 
although in previous studies the proportion of responsive cells was reported to be 
around 70% (Kirkman-Brown et al., 2000). This may be due to the difference in 
imaging techniques between the present study and that of Kirkman-Brown et al: open 
coverslip method and perfusion chamber method respectively. Furthermore, the 
method used to separate sperm from seminal plasma was via density gradient 
centrifugation, not swim-up as used by Kirkman-Brown et al; therefore it is possible 
that the populations of cells studied by the present and previous studies were different.  
The present study found no correlation between IVF fertilisation rates and proportion 
of cells responsive to progesterone, or extent of response. This is not altogether 
surprising; as discussed in Chapter 3 (screening of patients), there was no correlation 
between any of the parameters studied and IVF fertilisation rate. However as discussed 
previously, a total lack of response to progesterone was indicative of total fertilisation 
failure. None of the samples studied in the present study exhibited a total lack of 
response, therefore the hypothesis that this would lead to fertilisation failure could not 
be tested. 
Interestingly, it was found that although there was no significant correlation between 
ICSI patient average fluorescent intensity and fertilisation rates or proportion of 
responsive sperm versus fertilisation of MII oocytes only, there was a significant 
correlation between the proportion of responsive sperm and total fertilisation rate. This 
suggests that although ICSI bypasses the requirement of normal sperm function to 
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fertilise the oocyte, there may be some fundamental biological components within the 
sperm cell unable to be identified by the ICSI practitioner, yet linked with the ability 
of the sperm to produce a calcium response to progesterone, that are necessary for 
successful fertilisation. Unfortunately this effect was not observed when looking at 
the fertilisation rate of only MII oocytes, although this may be owing to the small 
sample size of ICSI patients with 4 or more oocytes to analyse for fertilisation rate (n 
= 9). Further investigation of ICSI patient sperm samples would strengthen the 
observations reported in this study. 
 
5.7 Conclusion 
The present study described a suitable method for screening sperm samples, 
particularly those with lower sperm numbers such as those seen in ICSI patient 
samples. The data presented here show that there is no significant difference between 
IVF, ICSI or donor samples in terms of proportion of sperm that positively respond to 
progesterone, or to what extent they respond (area under the curve). Furthermore, the 
data suggests that there is no correlation between proportion of responsive cells, nor 
extent of response in IVF patients, however total ICSI fertilisation rates are 
significantly correlated with the proportion of sperm significantly responsive to 
progesterone.  
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Chapter 6 
Donor semen cryopreservation and its effect on sperm calcium 
response to progesterone 
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6.1 Introduction 
Cryopreservation and thaw of human semen are fundamental and widely used 
techniques within the ART repertoire: to preserve reproductive capacity by enabling 
indefinite sperm storage in LN2 for a wide range of medical conditions and thaw for 
use in IUI, IVF and ICSI cycles (Anger et al., 2003). Cryopreservation of semen is 
necessary for quarantine of reproductive donor semen samples, and storage of semen 
pre-chemotherapy. However, the quality of sperm recovered post-thaw is 
unpredictable (Lee et al., 2012), and varies significantly between samples (Nallella et 
al., 2004). Relatively few studies have recently investigated how sperm function 
deteriorates after cryopreservation and thaw.  
In 1994, it was discovered that cryopreservation significantly affected calcium 
response to progesterone post-thaw in donor semen samples (McLaughlin and Ford, 
1994). Furthermore, cryopreservation has been shown to significantly negatively 
impact human donor sperm ability to penetrate bovine cervical mucus (Esfandiari et 
al., 2000), and also affects sperm morphology and motility (O'Connell et al., 2002). 
However these studies were carried out prior to knowledge of the role of the 
progesterone-sensitive CatSper channel on human sperm function (Smith et al., 2013). 
Considering that the human sperm calcium response to progesterone is of significant 
clinical importance (described in Chapters 3 and 4), the effect of cryopreservation on 
human sperm calcium regulation, and sperm function in general, clearly requires 
further investigation. 
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6.2 Aims 
The study aimed to investigate fresh and cryopreserved samples by applying 
previously described screening methods (Chapter 3), in order to determine if 
cryopreservation has a detrimental effect on calcium signalling after thaw.  
6.3 Hypothesis 
We hypothesised that cryopreservation and thaw of semen would have a significant 
detrimental effect on the regulation of calcium signalling in human spermatozoa. 
6.4 Experimental design 
 
Semen sample 
Wash 
Hyperactivation 
to 4-AP 
Fresh 
Fridge for 30min 
Liquid nitrogen vapour 
Viscous media 
penetration test 
Liquefy at 37°C 
Transfer to cryovial 
Thaw in water bath at 30°C 
Mix 1:1 with cryoprotectant 
Density gradient centrifugation 
Calcium response to 
progesterone 
Cryopreserved 
Single cell 
calcium imaging 
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Briefly, thirty four normozoospermic (exceeding WHO 2010 criteria for normal 
semen concentration and total motility) donor semen samples were divided into two 
aliquots: half was prepared fresh and half was cryopreserved and thawed before 
preparation, in a similar manner to previous studies (Rossato et al., 2000, Meseguer et 
al., 2004b). The fresh and frozen thawed semen samples were then subjected to one 
or more analysis techniques dependent on post-preparation sperm concentration: 
calcium response to 3.6µM progesterone, viscous media penetration test and 
hyperactivation in response to 2mM 4-AP. Calcium response to progesterone was 
performed using two methods: whole population analysis by FLUOstar Omega, and 
calcium imaging of individual cells. 
 
6.5 Results 
6.5.1 Sperm concentration and motility post-cryopreservation 
Thirty four semen samples were obtained from 21 donors. Due to significant inter-
donor and intra-ejaculate variation (see Section 2.7.4), all donor samples were 
considered as separate entities unless otherwise stated. After semen preparation, all 
fresh samples and thawed samples met the >1 million motile sperm criteria to be 
theoretically suitable for IVF in ACU Dundee. From examining the collective data 
obtained after basal and 2mM 4-AP induced motility analysis (Appendix Figure 6.1 
A-E displays data for sperm concentration, total motility, progressive, rapid, and 
hyperactivated motility, n=9 paired samples from 8 donors), fresh and frozen thawed 
samples showed no significant differences in concentration or any motility parameter 
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studied by computer aided semen analysis as displayed in Appendix Table 6.1 and 
Appendix Figure 6.1. 
6.5.2 Calcium response to progesterone – FLUOstar Omega population-based method 
Calcium response to progesterone was performed as described previously. Four 
million cells were used for either fresh or cryopreserved samples. The number of cells 
investigated per sample was not controlled by total motility, as previous experiments 
showed that there was no significant correlation between motility and peak calcium 
response to progesterone. Furthermore, motility analysis revealed that there was no 
significant difference in motility between prepared fresh and prepared cryopreserved 
samples (Appendix Figure 6.1).  
Of the 34 paired fresh and frozen thawed samples, all were able to produce a calcium 
response to progesterone. None of the donors completely failed to respond to 
progesterone after cryopreservation, although the peak calcium response for one donor 
in both the fresh and cryopreserved fraction of the sample was below the 5th centile 
for donors (as defined in Section 2.7.5). Overall as seen in Figure 6.1, there was a 
significant decrease in the peak (Figure 6.1 C, Student’s paired t-test, P=0.0046), delta 
(Figure 6.5.2 D, Student’s paired t-test, P=0.0046) and plateau phase calcium response 
(Figure 6.5.2 E, Wilcoxon signed rank test, P=0.0126) to progesterone after 
cryopreservation. There was a significant increase in the basal calcium ratio (Figure 
6.1 B, Wilcoxon signed rank test, P=0.0009), and the time to peak calcium response 
(Figure 6.1 F, Wilcoxon signed rank test, P=0.0279). The difference in the duration of 
response between fresh and frozen-thawed samples failed to reach statistical 
significance (Figure 6.1 G, Student’s paired t-test, P=0.0521).  
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Figure 6.1 Fresh versus cryopreserved calcium response to progesterone. Peak 
calcium response to progesterone, basal calcium level, delta response, plateau 
phase, time taken to reach peak and duration of peak were examined. N=34 paired 
donor samples. 
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6.5.3 Variation in calcium response to progesterone between individual donors 
Although the mean calcium response to progesterone was significantly reduced in 
sperm exposed to cryopreservation and thaw, this effect varied considerably between 
donors. For 26 of the 34 donor samples examined (76%), there was no significant 
difference in the calcium response for the fresh versus frozen-thawed sample (Figure 
6.2, represented by the trace of Donor 1, >75 but <125% of the fresh response). 
However, for 6 of the 34 donors samples (18%), peak calcium response recorded after 
cryopreservation was significantly reduced (Figure 6.2, representative trace presented 
of Donor 2, <75% of the fresh response,). Interestingly, two of the samples with 
reduced response came from the same donor. For two donors (6%), their frozen 
thawed response was significantly greater than fresh (>125% of the fresh response, 
data not shown). 
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Figure 6.2 Variation in response to cryopreservation between individual 
donors. Representative individual donor samples demonstrate the variability of 
proportionate change of peak calcium response to progesterone after 
cryopreservation. Some samples show no significant change, whereas others 
exhibit a drastic reduction (<75% of fresh) in peak response. The line represents 
100s, the arrow represents time of progesterone addition. 
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6.5.4 Calcium response to progesterone – single cell calcium imaging  
As described in Chapter 5, the single cell calcium imaging technique was performed 
on paired prepared fresh and prepared frozen-thawed donor samples, in order to 
ascertain whether the change in calcium response to progesterone was due to a change 
in the proportion of responsive cells or in the percentage increment in response to 
progesterone between samples. As described in Figure 6.3, there was no significant 
difference in the average area under the curve of progesterone-responsive cells in both 
treatment groups (Figure 6.3 A, 7682 ±8324SD versus 7462 ±5800SD, Wilcoxon 
matched pairs test, P=0.8926, n=12). When examining the proportion of cells 
positively responding to progesterone, there was also no significant difference 
between them (Figure 6.3 B, 50.63 ±25.01SD versus 56.17 ±25.25SD, Student’s 
paired t-test, P=0.5924, n=12).  
When analysing individual samples, four samples (33%) exhibited significantly 
reduced mean fluorescent intensity when stimulated with progesterone after 
cryopreservation, four samples (33%) showed the opposite where mean fluorescent 
intensity was significantly increased when stimulated with progesterone after 
cryopreservation, and four samples (33%) showed no significant difference. 
When analysing the mean basal fluorescence (background corrected), there was no 
significant difference observed between fresh and cryopreserved samples (Figure 6.3 
C, Wilcoxon matched pairs test, P=0.5693). 
123 
 
 Area under the curve
Fr
es
h
C
ry
o
0
10000
20000
30000
40000
F
lu
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
2
% cells positively
responding to progesterone
Fr
es
h
C
ry
o
0
20
40
60
80
100
%
 r
e
s
p
o
n
s
iv
e
A B
Single cell basal calcium fluorescence
Fr
es
h
C
ry
o
0
2000
4000
6000
8000
F
lu
o
re
s
c
e
n
c
e
 in
te
n
s
ity
C
 
 
 
 
6.5.5 Viscous media penetration test 
Fresh and frozen thawed samples of suitable cell number (were subjected to the 
viscous media penetration test (Ivic et al., 2002, Alasmari et al., 2013b), where 1-2 
million cells were incubated under control, vehicle (0.01% ethanol) and 3.6µM 
progesterone conditions. Sperm from both fresh and frozen thawed samples were able 
to penetrate into the methylcellulose, however there was a significant reduction in cell 
numbers at 1cm under control conditions after cryopreservation and thaw, as under 
fresh conditions median cell number was 38.5 ±20.39SD, whereas cryopreserved 
Figure 6.3. Single cell calcium response to progesterone after cryopreservation. 
Single cell calcium imaging revealed no significant difference between fresh and 
cryopreserved samples in average area under the curve or proportion of cells 
responding to progesterone. 
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median cell number was 22.14 ±19.1SD (Figure 6.4, Wilcoxon signed rank test, 
p<0.0001, n=9 paired fresh and cryopreserved samples from 8 donors). The data for 
all conditions at 1cm for fresh and cryopreserved samples is found in Table 6.1. 
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Vehicle 1cm 40.1 (19.2) 23.8 (16.1) 
Progesterone 1cm 86.1 (58.7) 36.4 (22.8) 
 
 
Figure 6.4 Viscous media penetration in fresh and cryopreserved samples. 
Fresh samples had a significantly greater cell density at 1cm under control 
conditions when compared to cryopreserved samples (Wilcoxon signed rank test, 
p<0.0001, n=9 paired fresh and cryopreserved samples from 8 donors). 
Table 6.1 Numbers of sperm reaching 1cm under control, vehicle and 
progesterone treated conditions. The figures represent mean number of sperm 
with SD in brackets. N=9. 
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Furthermore, fresh samples were able to significantly respond to progesterone in terms 
of increased cell number ratio found at 1cm in the methylcellulose following 1hr of 
incubation, however frozen thawed samples were unable to significantly respond to 
the addition of progesterone at 1cm (Figure 6.5).  
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6.5.6 Hyperactivation 
Fresh and frozen thawed spermatozoa were analysed for hyperactive motility using 
CASA. 2mM 4-AP was also used to stimulate hyperactivated motility. When looking 
at all samples together, both fresh and frozen thawed samples exhibited normal levels 
of hyperactivation after exposure to capacitating (control) conditions, and both were 
Figure 6.5 Viscous media penetration in response to progesterone pre-
treatment. Fresh sperm samples were on average able to respond significantly 
to progesterone at 1cm in the viscous media penetration test, however 
cryopreserved samples were unable to respond to progesterone on average (n=9 
pairs from 8 donors).  
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also able to significantly respond to 4-AP (Figure 6.6, A) control 17.64% ±11.69SD 
and 4-AP 33.83% ±11.41SD, Wilcoxon signed rank test P=0.0039, and B) control 
13.25% ±5.64 and 4-AP 22.72% ±11.04, Student’s paired t-test P=0.0170 respectively, 
n=9 paired samples from 8 donors). 
However when taking into account individual donor sperm responses to 4-AP, 8/9 
(89%) donors were able to significantly respond in fresh samples, whereas just 4/9 
(44%) donors were able to respond to 4-AP after cryopreservation. This indicates that 
half of the donors whose sperm originally significantly responded to 4-AP, lost this 
ability after cryopreservation and thaw. 
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Figure 6.6 Hyperactivation in response to 2mM 4-AP in fresh and 
cryopreserved samples. Sperm from both fresh and cryopreserved samples were 
able to significantly respond in terms of increment in hyperactivated motility in 
response to 4-AP (n=9 paired samples from 8 donors). 
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6.5.7 Cumulative poor responders 
There were 5 semen samples where if the sample responded poorly post-thaw to any 
of the tests subjected to, it would also perform poorly under one or more of the other 
tests. Taking the example of one of the donors whose fresh sample was able to 
significantly respond in the tests to both progesterone and 4-AP: fresh basal 
hyperactivation was significantly higher than cryopreserved basal hyperactivation, the 
cryopreserved sample showed no significant increment in hyperactivation in response 
to 4-AP, the cryopreserved sample calcium response to progesterone was just 68% of 
the fresh sample, and the cryopreserved sample was unable to significantly increment 
numbers of sperm in the viscous media under progesterone treatment. 
 
6.6 Discussion 
Multiple studies have shown that cryopreservation of semen leads to a decrease in 
sperm motility, concentration, morphology, mitochondrial activity and increases 
nuclear vacuolization when compared to their freshly prepared counterparts (Lin et 
al., 1998, Rossato et al., 2000, O'Connell et al., 2002, Boitrelle et al., 2012). However 
fresh semen analysis can seldom predict the quality of sperm recovered post-
cryopreservation and thaw (Meseguer et al., 2004b). Often in cases where time is 
sensitive, such as in the case of a pre-chemotherapy male, semen is cryopreserved 
without regard for sample quality, as ICSI may be utilised if the thawed sample quality 
is poor. However, although prospective sperm donors for reproductive purposes 
submit a semen sample for a “test thaw” to analyse sperm quality in terms of 
concentration and motility post-cryopreservation before acceptance as a donor, the 
thawed sperm function is not analysed, even though cryopreservation has been 
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demonstrated to have a significant detrimental effect on other aspects of sperm 
function such as the concentration of the sperm-derived oocyte activating factor PLCζ 
(Kashir et al., 2011). 
The data in the present study is based upon responses of normozoospermic (normal 
concentration and motility by WHO 2010 standards) research donor semen samples 
to cryopreservation and thaw. The data suggest that in contrast to previous studies 
(O’Connell, et al., 2002, Boitrelle, et al., 2012) cryopreservation has little significant 
negative effect on post-preparation sperm motility or concentration, however it 
exhibits a significant negative effect on normal sperm function: in particular the 
calcium signalling pathway and response to the stimulant progesterone. 
Cryopreservation also significantly impedes the ability of the sperm to penetrate a 
viscous media. These findings have serious implications for fertilisation both in vitro 
and in vivo, as evidenced by multiple previous studies (Falsetti et al., 1993, Shimizu 
et al., 1993, Krausz et al., 1995), sperm must maintain functional calcium signalling 
in response to progesterone in order for fertilisation to occur.  
As described previously (McLaughlin and Ford, 1994), in the present study 
cryopreserved sperm samples exhibited a significantly higher basal calcium ratio than 
their fresh counterparts, indicating a greater proportion of bound to unbound Fura dye. 
This in turn suggests that there was a greater concentration of free intracellular calcium 
within cryopreserved sperm cells. However this was not the case in single cell calcium 
imaging, where there was no significant difference between mean basal fluorescence 
(background corrected), between fresh and cryopreserved samples.  
Similarly to previous research (Rossato et al., 2000), the mean peak calcium response 
to progesterone was significantly reduced after cryopreservation and thaw. Further, 
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18% of donor samples in the present study exhibited a significant reduction in calcium 
response to progesterone after cryopreservation, however, 76% of donor samples 
showed little or no change following the cryopreservation procedure. As the technique 
used to freeze, thaw and prepare the sperm was identical for all samples, it stands to 
reason that an inherent sperm factor causes this change.  
Considering that two of the samples producing a reduced response to progesterone 
after cryopreservation were obtained from the same donor, it suggests that some donor 
sperm samples may be particularly susceptible to cryo-damage, due to genetic or 
epigenetic differences between subjects. It may therefore be prudent to assess 
individual donor susceptibility to cryo-damage in the laboratory workup before 
accepting them as donors for reproduction purposes, to avoid lower success rates with 
donors susceptible to the damage. 
Single cell calcium imaging showed that there was no significant difference in the 
proportions of sperm that were able to respond to progesterone between the fresh and 
frozen-thawed samples. However four individual samples within the twelve studied 
had a significant reduction in cellular fluorescence intensity post progesterone 
addition following cryopreservation, in agreement with results reported for samples in 
the FLUOstar. Intriguingly, a further third of these samples showed a significant 
increase in cellular fluorescence intensity post progesterone addition. It is of unknown 
cause, as only 6% of the samples showed a significantly increased calcium response 
to progesterone in the population assay. 
Esfandiari et al described in 2000 the significant negative effect of cryopreservation 
and thaw on the ability of sperm penetrating bovine cervical mucus. The further 
finding of the current study that under fresh sample conditions sperm are significantly 
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able to penetrate viscous media to a depth of 1cm in the viscous media penetration test 
however significantly fewer numbers of cryopreserved and thawed sperm are able to 
penetrate artificial viscous media at 1cm under control conditions correlates with these 
findings. This is of significant clinical importance: taking into consideration the 
widespread use of cryopreserved semen samples in IUI and IVF where although the 
cervical mucus challenge is artificially bypassed, sperm still have a fundamental role 
in penetrating the visco-elastic hyaluronan matrix surrounding the oocyte. 
Analysis of average basal hyperactivation of capacitated fresh and frozen-thawed 
sperm revealed no significant difference between the groups. However four individual 
samples showed a significant reduction in basal hyperactivation post-thaw. Eight of 
the nine fresh donor samples studied were able to significantly respond to 2mM 4-AP 
by significantly increasing the proportion of hyperactivated sperm. However in the 
cryopreserved group, only four of the nine samples were able to elicit the same 
significant response. As 4-AP is thought to exert its function via the mobilisation of 
calcium from intracellular stores in human sperm (Alasmari et al., 2013b), this result 
suggests that these membrane-bound calcium stores are dysfunctional or disrupted 
following cryopreservation in around half of all semen samples.  
A retrospective study found that fertilisation rates using fresh ejaculated sperm in ICSI 
were higher than using cryopreserved spermatozoa, even though the functional ability 
of the sperm is not required (Borges et al., 2007). Therefore, with respect to the current 
study, limitations include the lack of gold-standard experimental technique to prove 
correlation between poor post-thaw sperm function and fertilisation ability: 
determining sperm functional ability by either in vitro fertilisation to determine 
fertilisation rate or IUI to prove fertilisation by pregnancy achievement. These 
experiments, although informative, would be wholly unethical due to the findings of 
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the present study and that of Borges et al., of the negative impact on sperm function 
by cryopreservation.  
Further limitations include the reduction in viable cell number post-cryopreservation 
and thaw which in turn limited the number of different experiments able to be 
performed on each individual sample. It should be noted that the cryopreservation 
procedure itself results in an increased duration of sperm exposed to semen of around 
40 minutes, and also exposes the sperm to cryoprotectant for the same duration of 
time, excluding the time in liquid nitrogen storage. Failure to retrieve sufficient 
numbers of sperm post-thaw occurred in occasional individual cases resulted in 
reduction of potential n-numbers of paired samples to 34 detailed in this study. 
Furthermore, due to the timeline of performing the experiments, all hyperactivation 
assays, population-based calcium response to progesterone assays, and viscous media 
penetration tests were performed prior to single cell calcium imaging, preventing 
comparison of an individual sample performance in population versus single cell 
calcium response to progesterone. 
The semen samples analysed in the present study met the WHO 2010 criteria for 
normal values of sperm concentration and motility. It is crucial to consider that many 
of the semen samples cryopreserved within the Assisted Conception Unit are from 
patients who may exhibit oligo-, astheno-, teratozoospermia or a combination of the 
three. It has been previously reported that infertile patient semen samples with 
<50M/ml sperm concentration and <40% motility had significantly poorer post-thaw 
recovery (Mossad et al., 1994), therefore further investigation must be performed in 
order to establish post-thaw calcium response to progesterone outcome in these 
samples with poorer fresh semen parameters. These samples may be susceptible to 
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further cryo-damage and loss of function, which would significantly alter treatment 
outcome, and may lead to more invasive techniques such as ICSI. 
 
6.7 Conclusion 
In summary, cryopreservation does not affect sperm motility parameters however does 
have a novel significant negative impact on the human sperm calcium response to 
progesterone, and ability of these sperm to penetrate artificial viscous media following 
progesterone treatment. However this effect is highly variable between individual 
donors, and the impact on fertilisation potential following cryopreservation is as of yet 
unknown. 
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Chapter 7 
General Discussion 
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7.1 Review of the thesis aims and findings 
7.1.2 Thesis aims 
The aims of the present study were 1) to investigate incidence of calcium pathway 
defects in IVF patients and 2) patients recalled due to failed/low fertilisation, 3) to 
investigate the impact of cryopreservation on calcium pathway function, and 4) to 
initiate and develop the use of single cell calcium imaging as a more sensitive method 
for detecting calcium pathway dysfunction in IVF/ICSI patients and donors. 
 
7.1.3 Key findings 
The present study describes that, in contrast to previous studies, there was no 
significant difference in the parameters of the calcium response to progesterone 
between IVF patients and donors (Chapter 3). However the present study does confirm 
findings from a previous study (Alasmari et al., 2013a) that a reduced proportion of 
IVF patients (66%) were able to significantly respond to 4-AP treatment in terms of 
increase in hyperactivated motility compared with donors (80%), although these 
proportions were different than previously reported. The present study describes the 
novel attempt to use sperm penetration of viscous media under treatment with the 
known CatSper agonist, progesterone as previously described (Alasmari et al., 2013b), 
as a method of screening IVF patients for calcium pathway defects, and defects in 
sperm function. 
The present study describes, for the first time, the identification of two 
normozoospermic IVF patients with a complete absence of the ability of their sperm 
to produce a calcium response to progesterone. Previously, spermatozoa from one 
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male with homozygous CatSper2 deletion had been characterised with absence of 
CatSper current under electrophysiological measurement, however the spermatozoa 
had a myriad of other defects including asthenoteratozoospermia (Smith et al., 2013). 
Furthermore, the function of CatSper in this study was solely investigated using 
divalent-free Cs+ currents, not the direct monitoring of Ca2+ as performed in the 
current study. The normozoospermic patients described in the current study had 
unexplained total failed fertilisation of all inseminated oocytes during IVF. Both of 
these patients also failed to respond to progesterone treatment, in terms of enhancing 
cell numbers penetrating viscous media. Furthermore, both of these patients exhibited 
normal basal hyperactivation once exposed to capacitating conditions, unlike 
descriptions of sperm from mouse CatSper knockouts (Quill et al., 2003), thus the link 
between CatSper function and hyperactivation/fertilisation is complex in the human. 
Increase in hyperactivation via the calcium store-mobilising agent 4-AP was noted for 
both patients, indicating sufficient calcium store function. For one of the patients, the 
finding of CatSper channel dysfunction was confirmed by electrophysiological 
analysis, under Cs-based divalent free conditions. This finding is the first example of 
defective CatSper function in patients with normal semen parameters, and reinforces 
the message that CatSper deficiencies are not detectable by routine semen analysis 
techniques. Furthermore, the present study is the first to describe reversible CatSper 
function in an IVF patient, which then led to failed fertilisation when function was 
abolished. Reversible specific modification of the CatSper channel to alter function 
could therefore present a promising target for development of a novel contraceptive 
action, for use by either the male or female partner, as data from the current study 
suggests that sperm with non-functional CatSper are unable to fertilise oocytes. Novel 
CatSper antagonists which specifically inactivate the channel function would 
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potentially be beneficial, although specificity is key in this case, to reduce the risk of 
off-target effects on other calcium channels present systemically. 
The present study also demonstrated, in a novel manner, the detrimental effect of 
semen cryopreservation on calcium regulation and CatSper function post-thaw. 
Although none of the samples studied had CatSper function completely abolished after 
cryopreservation and thaw, the peak and plateau phase calcium response to 
progesterone were significantly reduced. Looking at fresh and cryopreserved samples 
from individual males revealed that some donors were particularly susceptible to 
cryodamage, while others showed little noticeable difference. This could indicate 
genetic/epigenetic variances between individuals, resulting in the observed 
cryodamage. This is a significant finding, particularly within the clinical context 
where semen cryopreservation and thaw is routinely used for procedures such as IUI 
and IVF. Furthermore, while basal hyperactivation was not significantly different 
between fresh and cryopreserved samples, cryopreservation reduced the proportion of 
samples able to significantly respond to 4-AP (89% for fresh samples versus 44% for 
cryopreserved samples with 4-AP treatment). This is a potentially significant finding, 
as increment of hyperactivation has been previously correlated with IVF fertilisation 
rate (Alasmari et al., 2013a), although this correlation was not observed in the present 
study (Chapter 3). 
The present study also demonstrated that single cell calcium imaging is an effective 
method for analysis of calcium response to progesterone in IVF and ICSI patient 
samples. Although fewer sperm are analysed per experiment (~200 versus 4 million 
for population-based methods), the technique benefits from increased sensitivity and 
specificity for single cell studies. This is particularly of use for ICSI samples where 
low sperm numbers render population methods impractical, but where significant 
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variation in the value of area under the curve between cells is evident (Chapter 5). The 
increased resolution obtained by analysing single cells could further localise and 
quantify (by proportions of responsive cells, or extent of response to progesterone as 
shown in Chapter 5) defective calcium regulation within a range of IVF and ICSI 
patients, as well as investigating patients with experience of a total failed fertilisation 
cycle. 
 
7.2 Clinical relevance 
This study investigated spermatozoa from male IVF and ICSI patients undergoing 
ART in Dundee. There were two main pools of patients investigated. The first pool 
were those undergoing routine IVF/ICSI who donated the surplus sample to research, 
not to directly benefit themselves but to potentially benefit others via the findings of 
the screening research carried out. The second pool were those patients who had 
experienced a failed/low fertilisation in a previous ART cycle, who donated a further 
semen sample solely for the investigation into causes of male factor infertility 
affecting this couple.  
The screening research carried out in Chapter 3 and Chapter 4 identified two men with 
defective calcium response to progesterone, and subsequent failed fertilisation. It is 
key to note that conversely, no patients were identified with defective calcium 
response to progesterone, with subsequent normal fertilisation. This study indicated 
that for the remainder of the IVF patients studied, there was no correlation found 
between any of the parameters studied with fertilisation rates in IVF. Furthermore, 
less than 1% of the samples studied had a severely defective calcium response to 
progesterone. The incidence of defects in calcium response to progesterone is low, and 
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the overwhelming majority will be “normal” with regard to calcium pathway function. 
However, screening a portion of cells from the IVF sample by FLUOstar after semen 
preparation and capacitation however prior to insemination could direct the 
embryologists to ICSI insemination rather than IVF, if a defect was noted.  This could 
result in the avoidance of failed fertilisation outcome for these patients, which would 
clearly have significant financial, clinical and emotional benefits for both the patients 
and clinical staff. This would be entirely possible in the ACU in Ninewells, where 
there is access to a FLUOstar machine in the research laboratory which is located 
within the same hospital. If all IVF patients cannot be screened, then priority should 
be for those who have unexplained infertility, as there was a disproportionate number 
of patients suffering from unexplained infertility in Chapter 4, two of whom had 
defective calcium response to progesterone. 
The research in Chapter 4 presents a very different story: where defects in calcium 
pathways or impaired K+ conductance were noted for a larger proportion of the patient 
samples investigated. For the defects that may be rectified by ICSI in the following 
cycle, such as absent calcium response to progesterone, the information gained by this 
screening technique would provide valuable information to the patient about why the 
failed/low fertilisation occurred. Furthermore it would provide vital information to the 
clinician regarding the direction that further treatment should take: for example an IVF 
attempt using an oocyte donor, where CatSper dysfunction was observed in the male 
partner, would be futile.  
Many research techniques are offered as adjuncts during infertility treatment, whether 
they are based upon sound scientific evidence with clear clinical benefit, or not 
(Harper et al., 2012). The patients are often charged for carrying out these extra 
techniques, unless they are part of an ongoing clinical trial. Thinking about the 
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screening methods used in the current thesis, it is unlikely that all NHS assisted 
reproduction clinics will have access to the equipment required (for example a 
FLUOstar, or single cell calcium imaging microscope setup). However, all clinics 
should have access to cryopreservation facilities for semen. If a clinician wanted to 
examine a semen sample for calcium pathway abnormalities, for example after a failed 
fertilisation in IVF where semen parameters were normal, they could ship the sample 
in LN2 for analysis by our laboratory. The cost would be relatively cheap (the most 
expensive step being shipping the sample), it would involve using the process of 
semen cryopreservation and shipping which is used routinely in the clinical laboratory, 
and the answer could be given within a day of receipt of the sample. This rapid 
turnaround of results could be particularly useful for those patients already in the early 
phases of a treatment cycle, prior to oocyte retrieval and fertilisation stages. Chapter 
6 demonstrated that although there is a significant reduction in peak calcium response 
to progesterone after cryopreservation when examined by FLUOstar Omega plate 
reader, none of the 34 samples examined completely lost the ability to respond to 
progesterone. Furthermore, using single cell calcium imaging, there was no significant 
difference in proportion of responsive cells to progesterone or extent of the response. 
Thus, either of these non-invasive, rapid techniques could be used to accurately 
analyse an external patient’s calcium response to progesterone.  
 
7.3 Further study 
Chapter 3 examined the effect of CatSper agonists (progesterone, and TMA via 
intracellular alkalization) and calcium store mobiliser (4-AP) on IVF patients and 
donors. There are many other compounds found to have effects on calcium pathways 
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in sperm: for example the activation of CatSper via prostaglandins, odorants (Brenker 
et al., 2012) and endocrine disruptors such as p,p’-DDE (Tavares et al., 2013). 
Therefore investigation must focus on determining the action of these other 
compounds on calcium regulation, particularly with reference to their involvement in 
male factor infertility. Also of significant interest may be the role played by follicular 
fluid on stimulating modifications in intracellular calcium, as a method more 
representative of the in vivo environment the sperm are exposed to while traversing 
the human female reproductive tract. Furthermore, investigation into drug discovery 
may reveal compounds that by acting on sperm calcium regulation are able to provide 
suitable therapeutic aid for patients suffering from poor sperm motility, as drugs 
targeting other fundamental sperm functions such as phosphodiesterase activity have 
already shown potential benefit in Andrology, IVF and ICSI patients (Tardif et al., 
2014). Thus, activators of calcium pathways in human sperm could be harnessed for 
therapeutic benefit, rather than being used for diagnostic analysis as described in the 
present study. 
For the patient samples received in Chapter 4, further study of further semen samples 
from this select group of patients who had experienced low/failed fertilisation would 
benefit from more sensitive techniques such as single cell calcium imaging in response 
to progesterone, in order to ascertain whether the pattern of response or proportion of 
responding cells were significantly different from IVF patients and donors. This would 
also enable the examination of spermatozoa from semen samples of low sperm 
concentration, which in the current study was not possible using the FLUOstar Omega 
microplate reader. 
Other future work should include further developments of the techniques described in 
Chapter 5. For example, use of a perfusion chamber with a closed bath would 
141 
 
circumvent the difficulties with manual addition of stimuli, avoid excessive 
evaporation, and would therefore extend the duration of recording to 10 – 30 minutes 
as described in other studies (Kirkman-Brown et al., 2000, Kirkman-Brown et al., 
2004). This would enable the study of the secondary phase of the intracellular calcium 
response to progesterone, and furthermore may enable the observation of calcium 
oscillations after progesterone treatment, which may be of clinical interest in the IVF 
and ICSI patient samples (Harper et al., 2004, Kirkman-Brown et al., 2004). As 
previously mentioned, evolution of this method to allow analysis of severely 
oligo/asthenozoospermic samples, or samples from patients recalled due to a 
failed/low fertilisation treatment outcome, would be beneficial. 
For the development of understanding of the impact of cryopreservation on the 
ultimate human sperm function, fertilisation of the oocyte, the gold standard would be 
to assess an aliquot of fresh and cryopreserved semen for calcium response to 
progesterone, and inseminate half of the oocytes with fresh prepared spermatozoa and 
half with thawed spermatozoa. This is not ethical, due to the fact that cryopreservation 
introduces abnormalities into the sperm that could negatively impact fertilisation 
(Esfandiari et al., 2000, O'Connell et al., 2002, Boitrelle et al., 2012). One way around 
this conundrum is to use a situation where cryopreservation and thaw is unavoidable, 
and furthermore no male factor infertility is present: such as using semen from a donor 
that would be used for reproductive purposes (for example use in IUI treatment 
cycles). This would not have a significant negative effect on the clinical treatment of 
the patients, as the standard donor tends to produce enough semen for many more vials 
of cryopreserved semen than are required for the limit of 10 families. Furthermore, a 
test thaw is always carried out prior to the donor being accepted, to assess the quality 
of his sample post-thaw, therefore examination could be performed on this sample. 
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Although a direct comparison with pregnancy rates with insemination using fresh 
semen is not possible, the technique could identify donors with increased 
susceptibility to cryodamage and thus increased time to pregnancy in inseminated 
patients. The reduction in calcium response to progesterone following 
cryopreservation as compared to the fresh aliquot could be compared with number of 
insemination cycles required to achieve a pregnancy. It must be noted that female 
infertility could be a confounding factor in this case, therefore care must be taken when 
interpreting the results.  
 
7.4 Conclusions 
The conclusions from this study are that while dysfunction of CatSper is rare in the 
general population and in the IVF patient population, the incidence rises when patients 
with total failed fertilisation are examined. Patients with unexplained total failed 
fertilisation may benefit from the use of single cell calcium imaging as a more 
sensitive method to screen for calcium defects within individual cells from a 
population. As cryopreservation does not significantly affect either the extent of 
calcium response to progesterone within the population of cells, or proportion of 
responsive cells, semen samples may be cryopreserved and transported for analysis by 
our laboratory for further investigation into calcium pathway defects.  
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Publications 
Williams HL, Mansell S, Alasmari W, Brown SG, Wilson SM, Sutton KA, Miller MR, 
Lishko PV, Barratt CL, Publicover SJ and Martins da Silva S. Specific loss of CatSper 
function is sufficient to compromise fertilizing capacity of human spermatozoa. Hum 
Reprod 2015;30:2737–2746. 
Brown SG, Publicover SJ, Mansell SA, Lishko PV, Williams HL, Ramalingam M, 
Wilson SM, Barratt CLR, Sutton KA and Martins Da Silva S. Depolarization of sperm 
membrane potential is a common feature of men with subfertility and is associated 
with low fertilisation rate at IVF. Hum Reprod 2016, first published online 6th April 
2016. 
I collaborated with Dr Sarah Martins da Silva to write a book chapter for joint 
publication between Royal College of Obstetricians and Gynaecologists and British 
Fertility Society: “Chapter 3: Semen analysis and sperm function tests” (in press).  
 
Presentations 
Fertility 2015 (7-9 January, ICC Birmingham) oral presentation entitled 
“Identification of putative CatSper defects in two IVF patients”. 
CMDN (College of Medicine, Dentistry and Nursing) poster presentation (February 
2015) entitled “Putative CatSper defects in two IVF patients”.  
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Characteristic 5th centile lower reference limits 
Volume 1.5ml 
Concentration 15M/ml 
Count (per ejaculate) 40M/ejaculate 
Total motility 40% 
Progressive motility 32% 
Normal forms 4% 
 
  Appendix Table 1. Semen characteristics. Replicate table of “normal” semen 
characteristics as defined by WHO (2010) 5th centile lower reference limits. 
174 
 
 
 
 
 
 
Quinn’s Advantage 
Fertilization HTF 
Universal Medium 
Quinn’s Sperm Washing 
Medium 
HTF (Lishko et al 2011) 
Sodium chloride 
Potassium chloride 
Sodium bicarbonate 
Glucose, D- (+) 
Sodium Pyruvate 
Phenol Red 
Gentamicin 
Alanyl-glutamine 
Taurine 
EDTA 
Potassium phosphate, 
monobasic, anhydrous 
Magnesium sulphate 
heptahydrate 
 
Asparagine 
Aspartic acid 
Glycine 
Proline 
Serine 
Calcium lactate (L+) 
Citric acid 
Serum protein 
substitute (5mg/ml) 
Sodium chloride 
Potassium chloride 
Sodium bicarbonate 
Glucose 
Sodium pyruvate 
Phenol red 
Gentamicin 
Alanyl-glutamine 
Taurine 
EDTA 
Potassium phosphate, 
anhydrous 
Magnesium sulphate 
 
 
Calcium chloride 
HEPES 
Sodium lactate (DL) 
Human serum albumin 
 
 
 
Sodium chloride (97.8mM) 
Potassium chloride (4.69mM) 
 
Glucose (2.78mM) 
Sodium pyruvate (0.33mM) 
 
 
 
 
 
 
 
Magnesium sulphate (0.2mM) 
 
 
Calcium chloride (2.04mM) 
HEPES (21mM) 
Lactic acid (21.4mM) 
0.3% BSA 
NaOH to pH-balance 
Appendix Table 2.1. Components in media used in the study. Components of 
Quinn’s Advantage Fertilisation (HTF) Universal Medium, Quinn’s Sperm 
Washing Medium, and HTF (based on Lishko et al 2011) are listed for comparison. 
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 Definition Measurement units 
VAP Average path 
velocity 
µM/sec 
VSL Straight line velocity µM/sec 
VCL Curvilinear velocity µM/sec 
ALH Amplitude of the 
lateral head 
displacement 
µM 
BCF Beat cross frequency Hz 
STR Straightness % 
LIN Linearity % 
Total Motile Total % of motile 
cells 
% 
Progressive % of progressive 
cells 
% 
Rapid % of rapid cells % 
Hyperactivation % of hyperactivated 
cells 
% 
 
 
 
 
 
 
  
Appendix Table 2.2 CASA motility parameters. Sperm motility parameters 
measured by computer assisted sperm analysis (CASA), and their measurement 
units. 
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 Concentration 
(M/ml) 
Total Motile 
% 
Progressive 
Motile % 
Rapid Motile 
% 
Donor 
semen 
119.9 (11.4) 66.5 (2.5) 38.2 (2.1) 56.2 (2.5) 
 Concentration 
(M/ml) 
Total 
Motile 
% 
Progressive 
Motile % 
Rapid 
Motile % 
Hyperactive 
% 
Donor 38.1 (5) 85.3 (1.5) 50.5 (2.6) 81.6 (1.7) 18 (1.6) 
 
IVF 17.1 (1.3) 79.5 (1.5) 50.3 (1.5) 74.9 (1.5) 13.5 (1.1) 
p 
value 
<0.0001 0.014 0.95 0.008 0.021 
Appendix Table 3.1 Mean sperm concentration and initial motility 
parameters for donor semen ±SEM. Donor sample n=47 ejaculates from 20 
donors.  
Appendix Table 3.2 A comparison of sperm concentration and motility 
parameters for prepared (resuspended in capacitating HTF media) samples 
±SEM. Donor n=48 ejaculates from 20 donors. IVF patient n=68. 
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Parameter Fresh Cryopreserved 
VAP 83.6 (6.8) 75.2 (8.9) 
VSL 69.1 (5.7) 60 (9.3) 
VCL 126.4 (17) 126.8 (14.6) 
ALH 4.7 (0.7) 5 (0.4) 
BCF 20.5 (3.6) 22.6 (4) 
STR 80.9 (6) 77.6 (4.7) 
LIN 57.4 (9.3) 50 (6.1) 
Concentration 18.5 (14.4) 22.4 (20.8) 
Motility 76.9 (14) 68.9 (9.9) 
Progressive 49.4 (13.7) 38.6 (9.4) 
Rapid 73.5 (13.8) 63.3 (9.5) 
Hyperactive 12.79 (4.50) 12.54 (5.92) 
 
 
 
 
 
Appendix Table 6.1. Motility parameters for fresh and cryopreserved sperm 
samples. There was no significant difference in any motility parameter observed 
between fresh and cryopreserved prepared sperm samples. Table shows mean 
values, the number in brackets denotes 1SD. 
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Appendix Figure 6.1 Motility parameters for fresh and cryopreserved 
samples. There was no significant difference in any motility parameter observed 
between fresh and cryopreserved prepared sperm samples, n=9 paired samples 
from 8 donors. 
